Josiah D. Rich, MD, MPH is Professor of Medicine and Epidemiology at The Warren Alpert Medical School of Brown University, and a practicing Infectious Disease Specialist since 1994 at The Miriam Hospital Immunology Center providing clinical care for 30 years, and at the Rhode Island Department of Corrections caring for prisoners with HIV infection and other medical problems along with working in the correctional setting doing research. He has published over 250 peer-reviewed publications, predominantly in the overlap between infectious diseases, addictions and incarceration. He is the Senior Medical Advisor and Co-founder of The Center for Health and Justice Transformation at The Miriam Hospital (HealthandJustice.org). Dr. Rich has advocated for public health policy changes to improve the health of people with addiction, including improving legal access to sterile syringes and increasing drug treatment for the incarcerated and formerly incarcerated populations. He has had continuous federal research funding since 1995 and is Principal or Co-Investigator on numerous ongoing grants. His primary field and area of specialization and expertise is in the overlap between infectious diseases and illicit substance use, the treatment and prevention of HIV infection, and the care and prevention of disease in addicted and incarcerated individuals. He has served as an expert for the National Academy of Sciences, the Institute of Medicine and many others. He has been appointed by former RI Governor, Gina Raimondo, to the Overdose Prevention and Intervention Task Force Expert Team, selected to advise the task force and formulate a strategic plan to address addiction and stop overdose in Rhode Island. The RI Overdose Prevention and Intervention Task Force was created to propose a strategic plan that puts forth the most impactful initiatives in the areas of prevention of opioid addiction, reversal of opioid overdose, treatment of opioid addiction, and recovery to reduce addiction and stop overdose death in Rhode Island. Their efforts are targeted at identifying the components for prevention, treatment, reversal, and recovery that will ‘shift the epidemic curve’ of overdose deaths.
| Frueh L, Collins AB, Newman R, Barnett NP, Rich JD, Clark MA, Marshall BDL, Macmadu A. "Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation." Harm Reduction Journal, vol. 20, no. 1, 2023, pp. 14. |
| Lombardi, Alexa Rose, Arya, Ritikraj, Rosen, Joseph G., Thompson, Erin, Welwean, Ralph, Tardif, Jessica, Rich, Josiah D., Park, Ju Nyeong. "Overdose Detection Technologies to Reduce Solitary Overdose Deaths: A Literature Review." International Journal of Environmental Research and Public Health, vol. 20, no. 2, 2023, pp. 1230. |
| Green TC, Serafinski R, Clark SA, Rich JD, Bratberg J. "Physician-Delegated Unobserved Induction with Buprenorphine in Pharmacies." New England Journal of Medicine, vol. 388, no. 2, 2023, pp. 185-186. |
| Kaplowitz E, Macmadu A, Green TC, Berk J, Rich JD, Brinkley-Rubinstein L. "It's probably going to save my life;" attitudes towards treatment among people incarcerated in the era of fentanyl." Drug and Alcohol Dependence, vol. 232, 2022, pp. 109325. |
| Kaplowitz E, Truong A, Macmadu A, Berk J, Martin H, Burke C, Rich JD, Brinkley-Rubinstein L. "Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration." Journal of Addiction Medicine, vol. 17, no. 1, 2022, pp. 54-59. |
| Macmadu A, Frueh L, Collins AB, Newman R, Barnett NP, Rich JD, Clark MA, Marshall BDL. "Drug use behaviors, trauma, and emotional affect following the overdose of a social network member: A qualitative investigation." International Journal of Drug Policy, vol. 107, 2022, pp. 103792. |
| Sun T, Katenka N, Kogut S, Bratberg J, Rich J, Buchanan A. "Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States." Pharmacoepidemiology, vol. 1, no. 3, 2022, pp. 101-112. |
| Bernstein MH, Rosenfield MN, Blease C, Magill M, Terek RM, Savulescu J, Beaudoin FL, Rich JD, Wartolowska K. "How do US orthopaedic surgeons view placebo-controlled surgical trials? A pilot online survey study." Journal of Medical Ethics, 2022. |
| Scherzer C, Jiménez Muñoz P, Ramsey S, Carey KB, Ranney ML, Clark S, Rich J, Langdon KJ. "Perceptions of medications, program settings, and drug use histories among individuals engaged in treatment for opioid use disorder." Journal of addictive diseases, 2022, pp. 1-9. |
| Jawa R, Walley AY, Wilson DJ, Green TC, McKenzie M, Hoskinson R Jr, Bratberg J, Ramsey S, Rich JD, Friedmann PD. "Prescribe to Save Lives: Improving buprenorphine prescribing among HIV clinicians." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 90, no. 5, 2022, pp. 546-552. |
| Skarha J, Dominick A, Spangler K, Dosa D, Rich JD, Savitz DA, Zanobetti A. "Provision of Air Conditioning and Heat-Related Mortality in Texas Prisons." JAMA Network Open, vol. 5, no. 11, 2022, pp. e2239849. |
| Del Pozo B, Rich JD, Carroll JJ. "Reports of accidental fentanyl overdose among police in the field: Toward correcting a harmful culture-bound syndrome." International Journal of Drug Policy, vol. 100, 2022, pp. 103520. |
| Martin RA, Berk J, Rich JD, Kang A, Fritsche J, Clarke JG. "Use of long-acting injectable buprenorphine in the correctional setting." Journal of Substance Abuse Treatment, vol. 142, 2022, pp. 108851. |
| Wu, Joseph H., Rich, Josiah D., Adashi, Eli Y. "Addiction Medicine After COVID-19: The Imperative of a Trained Workforce." American Journal of Preventive Medicine, vol. 60, no. 5, 2021, pp. 729-731. |
| Del Pozo B, Rich JD. "Addressing Racism in Medicine Requires Tackling the Broader Problem of Epistemic Injustice." The American journal of bioethics : AJOB, vol. 21, no. 2, 2021, pp. 90-93. |
| Howell, Benjamin A., Martin, Rosemarie A., Lebeau, Rebecca, Truong, Ashley Q., Wang, Emily A., Rich, Josiah D., Clarke, Jennifer G. "Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System." Health Affairs, vol. 40, no. 8, 2021, pp. 1304-1311. |
| Green TC, Kaplowitz E, Langdon K, Hughto JMW, Goedel WC, Czynski AJ, Fraser G, Rich J. "COBRE on Opioid and Overdose: A Collaborative Research-Based Center Addressing the Crises in Rhode Island and Beyond." Rhode Island medical journal (2013), vol. 104, no. 3, 2021, pp. 22-26. |
| Rogers R, Shehadeh F, Mylona EK, Rich J, Neill M, Touzard-Romo F, Geffert S, Larkin J, Bailey JA, Lu S, Sweeney J, Mylonakis E. "Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study." Clinical Infectious Diseases, vol. 73, no. 1, 2021, pp. e208-e214. |
| Crable, Erika L., Blue, Thomas R., McKenzie, Michelle, Rich, Josiah D., Gordon, Michael S. "Effect of Case Management on HIV Outcomes for Community Corrections Population: Results of an 18-Month Randomized Controlled Trial." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 87, no. 1, 2021, pp. 755-762. |
| Langdon KJ, Scherzer C, Ramsey S, Carey K, Rich J, Ranney ML. "Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder." Journal of Substance Abuse Treatment, vol. 131, 2021, pp. 108538. |
| Kaplowitz E, Truong AQ, Macmadu A, Peterson M, Brinkley-Rubinstein L, Potter N, Green TC, Clarke JG, Rich JD. "Fentanyl-related overdose during incarceration: a comprehensive review." Health & Justice, vol. 9, no. 1, 2021, pp. 13. |
| Papp MA, Leff JA, Murphy SM, Yang A, Crane HM, Metsch LR, Del Rio C, Feaster DJ, Rich JD, Schackman BR, McCollister KE. "Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research." Substance abuse treatment, prevention, and policy, vol. 16, no. 1, 2021, pp. 32. |
| Bernstein, Michael H., Rosenfield, Maayan, Fuchs, Nathaniel, Magill, Molly, Blease, Charlotte R., Beaudoin, Francesca L., Rich, Josiah D., Wartolowska, Karolina, Terek, Richard M. "How orthopedic surgeons view open label placebo pills: Ethical and effective, but opposed to personal use." Journal of Psychosomatic Research, vol. 151, 2021, pp. 110638. |
| Fredericksen RJ, Whitney BM, Trejo E, Nance RM, Fitzsimmons E, Altice FL, Carrico AW, Cleland CM, Del Rio C, Duerr A, El-Sadr WM, Kahana S, Kuo I, Mayer K, Mehta S, Ouellet LJ, Quan VM, Rich J, Seal DW, Springer S, Taxman F, Wechsberg W, Crane HM, Delaney JAC. "Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohort." BMC Public Health, vol. 21, no. 1, 2021, pp. 2002. |
| Berk, Justin, del Pozo, Brandon, Rich, Josiah D., Lee, Joshua D. "Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting." Journal of Addiction Medicine, vol. 16, no. 4, 2021, pp. 396-398. |
| Murphy M, Ding A, Berk J, Rich J, Bayliss G. "Kidney Disease among People Who Are Incarcerated." Clinical journal of the American Society of Nephrology : CJASN, vol. 16, no. 11, 2021, pp. 1766-1772. |
| Blue, Thomas R., Gordon, Michael S., Crable, Erika L., Rich, Josiah D. "Long-term follow-up of individuals under community supervision who refused rapid HIV testing." Journal of Offender Rehabilitation, vol. 60, no. 5, 2021, pp. 329-340. |
| Macmadu A, Adams JW, Bessey SE, Brinkley-Rubinstein L, Martin RA, Clarke JG, Green TC, Rich JD, Marshall BDL. "Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study." International Journal of Drug Policy, vol. 91, 2021, pp. 102841. |
| Dunne, Eugene M., Rosen, Rochelle K., McTigue, Georgiana L., Jamison, Robert N., Yeh, Gloria Y., Rich, Josiah D., Carey, Michael P. "The Lived Experience of Managing HIV and Chronic Pain: Qualitative Interviews with Patients and Healthcare Providers." AIDS and Behavior, 2021. |
| Bernstein MH, Fuchs N, Rosenfield M, Weiss AP, Blease C, Locher C, Magill M, Rich J, Beaudoin FL. "Treating Pain With Open-Label Placebos: A Qualitative Study With Post-Surgical Pain Patients." The Journal of Pain, vol. 22, no. 11, 2021, pp. 1518-1529. |
| Berk J, Rich JD, Brinkley-Rubinstein L. "Why we vaccinate incarcerated people first." EClinicalMedicine, vol. 35, 2021, pp. 100864. |
| Wakeman SE, Green TC, Rich J. "An overdose surge will compound the COVID-19 pandemic if urgent action is not taken." Nature Medicine, vol. 26, no. 6, 2020, pp. 819-820. |
| Skarha, Julianne, Peterson, Meghan, Rich, Josiah D., Dosa, David. "An Overlooked Crisis: Extreme Temperature Exposures in Incarceration Settings." American Journal of Public Health, vol. 110, no. S1, 2020, pp. S41-S42. |
| Macmadu, Alexandria, Rich, Josiah D. "Commentary on Richardson et al . : Strategies to mitigate payment‐coincident drug‐related harms are urgently needed." Addiction, vol. 116, no. 3, 2020, pp. 546-547. |
| Goldman JE, Samuels EA, Rich JD, Marshall BDL. "Correlates of death during outpatient treatment for opioid use disorder: A national study." Journal of Substance Abuse Treatment, vol. 112, 2020, pp. 76-85. |
| Macmadu A, Berk J, Kaplowitz E, Mercedes M, Rich JD, Brinkley-Rubinstein L. "COVID-19 and mass incarceration: a call for urgent action." The Lancet. Public health, vol. 5, no. 11, 2020, pp. e571-e572. |
| Del Pozo B, Beletsky L, Rich JD. "COVID-19 as a Frying Pan: The Promise and Perils of Pandemic-driven Reform." Journal of Addiction Medicine, vol. 14, no. 5, 2020, pp. e144-e146. |
| Puing AG, Li X, Rich J, Nijhawan AE. "Emergency department utilization by people living with HIV released from jail in the US South." Health & Justice, vol. 8, no. 1, 2020, pp. 16. |
| Macmadu, Alexandria, Goedel, William C., Adams, Joëlla W., Brinkley-Rubinstein, Lauren, Green, Traci C., Clarke, Jennifer G., Martin, Rosemarie A., Rich, Josiah D., Marshall, Brandon D.L. "Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails." Drug and Alcohol Dependence, vol. 208, 2020, pp. 107858. |
| Tiruneh YM, Li X, Bovell-Ammon B, Iroh P, Flanigan TP, Montague BT, Rich JD, Nijhawan AE. "Falling Through the Cracks: Risk Factors for Becoming Lost to HIV Care After Incarceration in a Southern Jail." AIDS and Behavior, vol. 24, no. 8, 2020, pp. 2430-2441. |
| Aroke HA, Buchanan AL, Bratberg J, Hogan JW, Rich JD, Wen X, Kogut SJ. "Initial Patterns of Prescription Opioid Supply and Risk of Mortality Among Insured Adults in the United States." Journal of Addiction Medicine, vol. 15, no. 2, 2020, pp. 99-108. |
| Stone, Andrew C., Carroll, Jennifer J., Rich, Josiah D., Green, Traci C. "One year of methadone maintenance treatment in a fentanyl endemic area: Safety, repeated exposure, retention, and remission." Journal of Substance Abuse Treatment, vol. 115, 2020, pp. 108031. |
| Del Pozo B, Rich JD. "Revising our attitudes towards agonist medications and their diversion in a time of pandemic." Journal of Substance Abuse Treatment, vol. 119, 2020, pp. 108139. |
| Salisbury-Afshar EM, Rich JD, Adashi EY. "Vulnerable Populations: Weathering the Pandemic Storm." American Journal of Preventive Medicine, vol. 58, no. 6, 2020, pp. 892-894. |
| Mahowald MK, Larney S, Zaller ND, Scharff N, Taylor LE, Beckwith CG, Noska A, Rich JD, Flanigan TP. "Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012." Journal of Correctional Health Care, vol. 22, no. 1, 2016, pp. 41-5. |
| Noska, Amanda J., Roberts, Mary B., Sufrin, Carolyn, Stein, L.A.R., Beckwith, Curt G., Rich, Josiah D., Dauria, Emily F., Clarke, Jennifer G. "History of Sex Exchange in Women with a History of Incarceration." Journal of Health Care for the Poor and Underserved, vol. 27, no. 2A, 2016, pp. 149-162. |
| Montague, Brian T., Rosen, David L., Sammartino, Cara, Costa, Michael, Gutman, Roee, Solomon, Liza, Rich, Josiah. "Systematic Assessment of Linkage to Care for Persons with HIV Released from Corrections Facilities Using Existing Datasets." AIDS Patient Care and STDs, vol. 30, no. 2, 2016, pp. 84-91. |
| Nguyen, John T., Rich, Josiah D., Brockmann, Bradley W., Vohr, Fred, Spaulding, Anne, Montague, Brian T. "A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System." Journal of Urban Health, vol. 92, no. 4, 2015, pp. 635-649. |
| Nguyen JT, Rich JD, Brockmann BW, Vohr F, Spaulding A, Montague BT. "A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System." Journal of Urban Health, vol. 92, no. 4, 2015, pp. 635-49. |
| Wakeman, Sarah E., Rich, Josiah D. "Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care." Journal of addictive diseases, vol. 34, no. 2-3, 2015, pp. 220-225. |
| Levin, Susan, Wells, Cameron, Barnard, Neal. "Dietary Cholesterol and Blood Cholesterol Concentrations." JAMA, vol. 314, no. 19, 2015, pp. 2083. |
| Rich, Josiah D., Adashi, Eli Y. "Ideological Anachronism Involving Needle and Syringe Exchange Programs." JAMA, vol. 314, no. 1, 2015, pp. 23. |
| Rich JD, Adashi EY. "Ideological Anachronism Involving Needle and Syringe Exchange Programs: Lessons From the Indiana HIV Outbreak." JAMA, vol. 314, no. 1, 2015, pp. 23-4. |
| Rich, Josiah D, McKenzie, Michelle, Larney, Sarah, Wong, John B, Tran, Liem, Clarke, Jennifer, Noska, Amanda, Reddy, Manasa, Zaller, Nickolas. "Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial." The Lancet, vol. 386, no. 9991, 2015, pp. 350-359. |
| Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N. "Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial." The Lancet, vol. 386, no. 9991, 2015, pp. 350-9. |
| Brookes, Carolyn Dicus, Berry, John, Rich, Josiah, Golden, Brent A., Turvey, Timothy A., Blakey, George, Kopp, Vincent, Phillips, Ceib, Anderson, Jay. "Multimodal Protocol Reduces Postoperative Nausea and Vomiting in Patients Undergoing Le Fort I Osteotomy." Journal of Oral and Maxillofacial Surgery, vol. 73, no. 2, 2015, pp. 324-332. |
| Brookes CD, Berry J, Rich J, Golden BA, Turvey TA, Blakey G 3rd, Kopp V, Phillips C, Anderson J. "Multimodal protocol reduces postoperative nausea and vomiting in patients undergoing Le Fort I osteotomy." Journal of Oral and Maxillofacial Surgery, vol. 73, no. 2, 2015, pp. 324-32. |
| Rich JD, Adashi EY. "Needle Exchange Programs for HIV Outbreaks-Reply." JAMA, vol. 314, no. 19, 2015, pp. 2085-6. |
| Rich, Josiah D., Adashi, Eli Y. "Needle Exchange Programs for HIV Outbreaks—Reply." JAMA, vol. 314, no. 19, 2015, pp. 2085. |
| Phillips C, Brookes CD, Rich J, Arbon J, Turvey TA. "Postoperative nausea and vomiting following orthognathic surgery." International journal of oral and maxillofacial surgery, vol. 44, no. 6, 2015, pp. 745-51. |
| Ahalt, Cyrus, Wang, Emily A., Williams, Brie. "State of Research Funding From the National Institutes of Health for Criminal Justice Health Research." Annals of Internal Medicine, vol. 163, no. 3, 2015, pp. 240. |
| Lemon T, Spaulding A, Rich JD. "State of Research Funding From the National Institutes of Health for Criminal Justice Health Research." Annals of Internal Medicine, vol. 163, no. 3, 2015, pp. 240. |
| Wakeman, Sarah E, Rich, Josiah D. "Substance use disorders and avoidable mortality after prison." The Lancet Psychiatry, vol. 2, no. 5, 2015, pp. 369-370. |
| Wakeman SE, Rich JD. "Substance use disorders and avoidable mortality after prison." The Lancet Psychiatry, vol. 2, no. 5, 2015, pp. 369-70. |
| Beckwith, Curt G., Kurth, Ann E., Bazerman, Lauri, Solomon, Liza, Patry, Emily, Rich, Josiah D., Kuo, Irene. "Survey of US Correctional Institutions for Routine HCV Testing." American Journal of Public Health, vol. 105, no. 1, 2015, pp. 68-71. |
| Rich JD, Allen SA, Williams BA. "The need for higher standards in correctional healthcare to improve public health." J GEN INTERN MED, vol. 30, no. 4, 2015, pp. 503-7. |
| Hammett, Theodore M., Donahue, Sara, LeRoy, Lisa, Montague, Brian T., Rosen, David L., Solomon, Liza, Costa, Michael, Wohl, David, Rich, Josiah D. "Transitions to Care in the Community for Prison Releasees with HIV: a Qualitative Study of Facilitators and Challenges in Two States." Journal of Urban Health, vol. 92, no. 4, 2015, pp. 650-666. |
| Hammett TM, Donahue S, LeRoy L, Montague BT, Rosen DL, Solomon L, Costa M, Wohl D, Rich JD. "Transitions to Care in the Community for Prison Releasees with HIV: a Qualitative Study of Facilitators and Challenges in Two States." Journal of Urban Health, vol. 92, no. 4, 2015, pp. 650-66. |
| Larney S, G Beckwith C, D Zaller N, T Montague B, Rich J. "Seek, test, treat and retain" for hepatitis C in the United States criminal justice system." International Journal of Prisoner Health, vol. 10, no. 3, 2014, pp. 164-71. |
| Brockmann BW, Rosen DL, Dumont DM, Cislo AM, Rich JD. "Brockmann et al. respond." American Journal of Public Health, vol. 104, no. 8, 2014, pp. e4-5. |
| Reece RM, Cunha CB, Rich JD. "Corynebacterium minutissimum vascular graft infection: Case report and review of 281 cases of prosthetic device-related Corynebacterium infection." Scandinavian journal of infectious diseases, vol. 46, no. 9, 2014, pp. 609-16. |
| Green, T. C., Bowman, S. E., Ray, M., McKenzie, M., Lord, S. E., Rich, J. D. "Development of an incarceration-specific overdose prevention video: Staying Alive on the Outside." Health Education Journal, vol. 74, no. 5, 2014, pp. 627-637. |
| Green, Traci C., Bowman, S., Ray, M., McKenzie, M., Rich, J. "Feasibility of prison-based overdose prevention education and prescribed naloxone at release." Drug and Alcohol Dependence, vol. 140, 2014, pp. e74. |
| Wakeman SE, Green TC, Rich JD. "From documenting death to comprehensive care: Applying lessons from the HIV/AIDS epidemic to addiction." The American Journal of Medicine, vol. 127, no. 6, 2014, pp. 465-6. |
| Westergaard, Ryan P, Rich, Josiah D. "HIV and reincarceration: time for a comprehensive approach." The Lancet HIV, vol. 1, no. 2, 2014, pp. e54-e55. |
| Rich JD, Chandler R, Williams BA, Dumont D, Wang EA, Taxman FS, Allen SA, Clarke JG, Greifinger RB, Wildeman C, Osher FC, Rosenberg S, Haney C, Mauer M, Western B. "How health care reform can transform the health of criminal justice-involved individuals." Health Affairs, vol. 33, no. 3, 2014, pp. 462-7. |
| McNamara BC, Losikoff PT, Huguenin L, Macalino GE, Rich JD, Gregory SH. "Increasing hepatitis C prevalence and associated risk behaviors among incarcerated young adults." Journal of Urban Health, vol. 91, no. 2, 2014, pp. 376-82. |
| Patel K, Boutwell A, Brockmann BW, Rich JD. "Integrating correctional and community health care for formerly incarcerated people who are eligible for Medicaid." Health Affairs, vol. 33, no. 3, 2014, pp. 468-73. |
| Rosen DL, Dumont DM, Cislo AM, Brockmann BW, Traver A, Rich JD. "Medicaid policies and practices in US state prison systems." American Journal of Public Health, vol. 104, no. 3, 2014, pp. 418-20. |
| Zervou, F. N., Zacharioudakis, I. M., Ziakas, P. D., Rich, J. D., Mylonakis, E. "Prevalence of and Risk Factors for Methicillin-Resistant Staphylococcus aureus Colonization in HIV Infection: A Meta-Analysis." Clinical Infectious Diseases, vol. 59, no. 9, 2014, pp. 1302-1311. |
| Rich JD, Allen SA, Williams BA. "Responding to hepatitis C through the criminal justice system." New England Journal of Medicine, vol. 370, no. 20, 2014, pp. 1871-4. |
| Dumont, Dora M., Allen, Scott A., Rich, Josiah D. "Sesame Street Goes to Jail: Physicians Should Follow." Annals of Internal Medicine, vol. 161, no. 7, 2014, pp. 522. |
| Solomon L, Montague BT, Beckwith CG, Baillargeon J, Costa M, Dumont D, Kuo I, Kurth A, Rich JD. "Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment." Health Affairs, vol. 33, no. 3, 2014, pp. 434-42. |
| Beckwith C, Bazerman L, Gillani F, Tran L, Larson B, Rivard S, Flanigan T, Rich J. "The feasibility of implementing the HIV seek, test, and treat strategy in jails." AIDS Patient Care and STDs, vol. 28, no. 4, 2014, pp. 183-7. |
| Rich, Josiah D., Allen, Scott A., Williams, Brie A. "The Need for Higher Standards in Correctional Healthcare to Improve Public Health." J GEN INTERN MED, vol. 30, no. 4, 2014, pp. 503-507. |
| Green TC, Ray M, Bowman SE, McKenzie M, Rich JD. "Two cases of intranasal naloxone self-administration in opioid overdose." Substance Abuse, vol. 35, no. 2, 2014, pp. 129-32. |
| Larney S, Hado S, McKenzie M, Rich JD. "Unknown quantities: HIV, viral hepatitis, and sexually transmitted infections in community corrections." Sexually Transmitted Diseases, vol. 41, no. 4, 2014, pp. 283. |
| Green, Traci, Bowman, Sarah, Ray, Madeline, Kobayashi, Leo, McKenzie, Michelle, Rich, Josiah. "Board 339 - Research Abstract Patient Simulation for Assessment and Reinforcement of Layperson Management of Opioid Overdose with Intranasal Naloxone in a Recently Released Prison Inmate Cohort (Submission #66)." Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare, vol. 8, no. 6, 2013, pp. 538. |
| Rich JD, DiClemente R, Levy J, Lyda K, Ruiz MS, Rosen DL, Dumont D, Centers for AIDS Research at the Social and Behavioral Sciences Research Network, Centers for AIDS Research–Collaboration on HIV in Corrections Working Group. "Correctional facilities as partners in reducing HIV disparities." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 63 Suppl 1, 2013, pp. S49-53. |
| Echenique IA, Rich JD. "EFV/FTC/TDF-associated hepatotoxicity: a case report and review." AIDS Patient Care and STDs, vol. 27, no. 9, 2013, pp. 493-7. |
| Fu JJ, Zaller ND, Yokell MA, Bazazi AR, Rich JD. "Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States." Journal of Substance Abuse Treatment, vol. 44, no. 5, 2013, pp. 502-5. |
| Dumont, Dora M., Gjelsvik, Annie, Chen, Nadine, Rich, Josiah D. "Hispanics, incarceration, and TB/HIV screening: a missed opportunity for prevention." Journal of immigrant and minority health / Center for Minority Public Health, vol. 15, no. 4, 2013, pp. 711-717. |
| Larney S, Zaller ND, Rich JD. "HIV prevention, treatment, and care for people who inject drugs." The Journal of Infectious Diseases, vol. 208, no. 3, 2013, pp. 370-2. |
| Dumont DM, Allen SA, Brockmann BW, Alexander NE, Rich JD. "Incarceration, Community Health, and Racial Disparities." Journal of Health Care for the Poor and Underserved, vol. 24, no. 1, 2013, pp. 78-88. |
| Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, Rich JD, van den Bergh BJ, Degenhardt L. "Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis." Hepatology, vol. 58, no. 4, 2013, pp. 1215-24. |
| Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. "Initiation of buprenorphine during incarceration and retention in treatment upon release." Journal of Substance Abuse Treatment, vol. 45, no. 2, 2013, pp. 222-6. |
| Dumont, Dora M., Gjelsvik, Annie, Redmond, Nicole, Rich, Josiah D. "Jails as Public Health Partners: Incarceration and Disparities Among Medically Underserved Men." International Journal of Men's Health, vol. 12, no. 3, 2013, pp. 213-227. |
| Matusow H, Dickman SL, Rich JD, Fong C, Dumont DM, Hardin C, Marlowe D, Rosenblum A. "Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes." Journal of Substance Abuse Treatment, vol. 44, no. 5, 2013, pp. 473-80. |
| Beletsky L, Walley AY, Rich JD. "Opioid overdose fatality prevention--reply." JAMA, vol. 309, no. 9, 2013, pp. 874. |
| Ahalt C, Trestman RL, Rich JD, Greifinger RB, Williams BA. "Paying the price: the pressing need for quality, cost, and outcomes data to improve correctional health care for older prisoners." Journal of the American Geriatrics Society, vol. 61, no. 11, 2013, pp. 2013-9. |
| Gordon MS, Kinlock TW, McKenzie M, Wilson ME, Rich JD. "Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial." AIDS and Behavior, vol. 17, no. 6, 2013, pp. 2022-30. |
| Rich JD, Rich N, Rich N. "The Rich family’s mission to Eldoret." Rhode Island medical journal (2013), vol. 96, no. 9, 2013, pp. 25-7. |
| Rich, Josiah D., Cortina, Sandra C., Uvin, Zoe X., Dumont, Dora M. "Women, Incarceration, and Health." Women's Health Issues, vol. 23, no. 6, 2013, pp. e333-e334. |
| McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD. "A randomized trial of methadone initiation prior to release from incarceration." Substance Abuse, vol. 33, no. 1, 2012, pp. 19-29. |
| Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. "Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?." Journal of Addiction Medicine, vol. 6, no. 3, 2012, pp. 179-85. |
| Green TC, McGowan SK, Yokell MA, Pouget ER, Rich JD. "HIV infection and risk of overdose: a systematic review and meta-analysis." AIDS, vol. 26, no. 4, 2012, pp. 403-17. |
| Yokell MA, Zaller ND, Green TC, McKenzie M, Rich JD. "Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose." Journal of opioid management, vol. 8, no. 1, 2012, pp. 63-6. |
| Rich JD, Clarke JG, Adashi EY. "Obstetrical and gynecological training in the correctional setting: learning to care for the most vulnerable patients." Journal of Graduate Medical Education, vol. 4, no. 3, 2012, pp. 387-8. |
| Lee JD, Rich JD. "Opioid pharmacotherapy in criminal justice settings: now is the time." Substance Abuse, vol. 33, no. 1, 2012, pp. 1-4. |
| Yokell MA, Green TC, Rich JD. "Prescription drug monitoring programs." JAMA, vol. 307, no. 9, 2012, pp. 912; author reply 912-3. |
| Beletsky L, Rich JD, Walley AY. "Prevention of fatal opioid overdose." JAMA, vol. 308, no. 18, 2012, pp. 1863-4. |
| Dumont DM, Brockmann B, Dickman S, Alexander N, Rich JD. "Public Health and the Epidemic of Incarceration." Annual review of public health, vol. 33, no. 1, 2012, pp. 325-39. |
| Zaller ND, Yokell MA, Nayak SM, Fu JJ, Bazazi AR, Rich JD. "Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island." Journal of Urban Health, vol. 89, no. 4, 2012, pp. 659-70. |
| Montague, Brian T., Rosen, David L., Solomon, Liza, Nunn, Amy, Green, Traci, Costa, Michael, Baillargeon, Jacques, Wohl, David A., Paar, David P., Rich, Josiah D. "Tracking linkage to HIV care for former prisoners: A public health priority." Virulence, vol. 3, no. 3, 2012, pp. 319-324. |
| Taylor LE, DeLong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, Rich J, Mayer KH. "Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk." AIDS Patient Care and STDs, vol. 25, no. 10, 2011, pp. 571-7. |
| Rich, Josiah D., McKenzie, Michelle, Dickman, Samuel, Bratberg, Jeffrey, Lee, Joshua D., Schwartz, Robert P. "An Adverse Reaction to Buprenorphine/Naloxone Induction in Prison." Addictive Disorders & Their Treatment, vol. 10, no. 4, 2011, pp. 199-200. |
| Christopher, Paul P., Candilis, Philip J., Rich, Josiah D., Lidz, Charles W. "An Empirical Ethics Agenda for Psychiatric Research Involving Prisoners." AJOB Primary Research, vol. 2, no. 4, 2011, pp. 18-25. |
| Yokell MA, Zaller ND, Green TC, Rich JD. "Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review." Current drug abuse reviews, vol. 4, no. 1, 2011, pp. 28-41. |
| Nunn A, Montague BT, Green T, Solomon L, Alexander N, Costa M, Rich J. "Expanding test and treat in correctional populations: a key opportunity to reduce racial disparities in HIV infection." Clinical Infectious Diseases, vol. 53, no. 5, 2011, pp. 499-500. |
| Rich, Josiah D., Wohl, David A., Beckwith, Curt G., Spaulding, Anne C., Lepp, Nathaniel E., Baillargeon, Jacques, Gardner, Adrian, Avery, Ann, Altice, Frederick L., Springer, Sandra. "HIV-related research in correctional populations: now is the time." Current HIV/AIDS Reports, vol. 8, no. 4, 2011, pp. 288-96. |
| Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND. "Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users." Journal of Addiction Medicine, vol. 5, no. 3, 2011, pp. 175-80. |
| Malek M, Bazazi AR, Cox G, Rival G, Baillargeon J, Miranda A, Rich JD. "Implementing opt-out programs at Los Angeles county jail: a gateway to novel research and interventions." Journal of Correctional Health Care, vol. 17, no. 1, 2011, pp. 69-76. |
| Rich JD, Wakeman SE, Dickman SL. "Medicine and the epidemic of incarceration in the United States." New England Journal of Medicine, vol. 364, no. 22, 2011, pp. 2081-3. |
| Yokell MA, Green TC, Bowman S, McKenzie M, Rich JD. "Opioid overdose prevention and naloxone distribution in Rhode Island." Medicine and health, Rhode Island, vol. 94, no. 8, 2011, pp. 240-2. |
| Rich JD, Green TC, McKenzie MS. "Opioids and deaths." New England Journal of Medicine, vol. 364, no. 7, 2011, pp. 686. |
| Fiscella K, Rich JD. "Pregnancy, addiction, and incarceration." JAMA, vol. 305, no. 24, 2011, pp. 2523; author reply 2523-4. |
| Green TC, Zaller N, Rich J, Bowman S, Friedmann P. "Revisiting Paulozzi et al.'s "Prescription drug monitoring programs and death rates from drug overdose"." Pain Medicine, vol. 12, no. 6, 2011, pp. 982-5. |
| Dickman SL, Rich JD. "The health of prisoners." The Lancet, vol. 377, no. 9782, 2011, pp. 2001-2. |
| Zaller ND, Yokell MA, Jeronimo A, Bratberg JP, Case P, Rich JD. "Adverse event associated with a change in nonprescription syringe sale policy." Journal of the American Pharmacists Association, vol. 50, no. 5, 2010, pp. 619-22. |
| Merchant RC, DePalo DM, Liu T, Rich JD, Stein MD. "Developing a system to predict laboratory-confirmed chlamydial and/or gonococcal urethritis in adult male emergency department patients." Postgraduate Medicine, vol. 122, no. 1, 2010, pp. 52-60. |
| Baillargeon JG, Giordano TP, Harzke AJ, Baillargeon G, Rich JD, Paar DP. "Enrollment in outpatient care among newly released prison inmates with HIV infection." public health reports, vol. 125 Suppl 1, 2010, pp. 64-71. |
| Wakeman SE, Rich JD. "Fulfilling the mission of academic medicine: training residents in the health needs of prisoners." J GEN INTERN MED, vol. 25 Suppl 2, 2010, pp. S186-8. |
| Wakeman, Sarah E, Rich, Josiah D. "HIV treatment in US prisons." HIV Therapy, vol. 4, no. 4, 2010, pp. 505-510. |
| Henderson CE, Rich JD, Lally MA. "HPV vaccination practices among juvenile justice facilities in the United States." Journal of Adolescent Health, vol. 46, no. 5, 2010, pp. 495-8. |
| NUNN, AMY, ZALLER, NICKOLAS, DICKMAN, SAMUEL, NIJHAWAN, ANK, RICH, JOSIAH D. "Improving access to opiate addiction treatment for prisoners." Addiction, vol. 105, no. 7, 2010, pp. 1312-1313. |
| Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. "Opportunities to diagnose, treat, and prevent HIV in the criminal justice system." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 55 Suppl 1, 2010, pp. S49-55. |
| Zaller N, Jeronimo A, Bratberg J, Case P, Rich JD. "Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI." Journal of Urban Health, vol. 87, no. 6, 2010, pp. 942-53. |
| Bazazi AR, Zaller ND, Fu JJ, Rich JD. "Preventing opiate overdose deaths: examining objections to take-home naloxone." Journal of Health Care for the Poor and Underserved, vol. 21, no. 4, 2010, pp. 1108-13. |
| Rich JD, Taylor LE. "The beginning of a new era in understanding hepatitis C virus prevention." The Journal of Infectious Diseases, vol. 202, no. 7, 2010, pp. 981-3. |
| Zaller ND, Fu JJ, Bazazi AR, Rich JD. "The impact of financial discharge from methadone maintenance therapy on incarceration." Journal of opioid management, vol. 6, no. 5, 2010, pp. 365-70. |
| Macalino GE, Sachdev DD, Rich JD, Becker C, Tan LJ, Beletsky L, Burris S. "A national physician survey on prescribing syringes as an HIV prevention measure." Substance abuse treatment, prevention, and policy, vol. 4, 2009, pp. 13. |
| Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, Paar DP. "Accessing antiretroviral therapy following release from prison." JAMA, vol. 301, no. 8, 2009, pp. 848-57. |
| Merchant RC, Depalo DM, Stein MD, Rich JD. "Adequacy of testing, empiric treatment, and referral for adult male emergency department patients with possible chlamydia and/or gonorrhoea urethritis." International journal of STD & AIDS, vol. 20, no. 8, 2009, pp. 534-9. |
| Zaller ND, Bazazi AR, Velazquez L, Rich JD. "Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities." International Journal of Environmental Research and Public Health, vol. 6, no. 2, 2009, pp. 787-97. |
| Gillani FS, Zaller ND, Zeller K, Rich JD, Cu-Uvin S, Flanigan TP, Carpenter CC. "Changes in demographics and risk factors among persons living with HIV in an academic medical center from 2003-2007." Medicine and health, Rhode Island, vol. 92, no. 7, 2009, pp. 237-40. |
| Martin TM, Rich JD. "Fatal HIV encephalitis in HIV-seronegative patients." Emerging infectious diseases, vol. 15, no. 1, 2009, pp. 129-31. |
| Wakeman SE, McKinney ME, Rich JD. "Filling the gap: the importance of Medicaid continuity for former inmates." J GEN INTERN MED, vol. 24, no. 7, 2009, pp. 860-2. |
| Wakeman SE, Zaller ND, Flanigan TP, Pinkston M, Montague BT, Rich JD. "HIV among marginalized populations in Rhode Island." Medicine and health, Rhode Island, vol. 92, no. 7, 2009, pp. 244-6. |
| Flanigan TP, Zaller N, Taylor L, Beckwith C, Kuester L, Rich J, Carpenter CC. "HIV and infectious disease care in jails and prisons: breaking down the walls with the help of academic medicine." Transactions of the American Clinical and Climatological Association, vol. 120, 2009, pp. 73-83. |
| Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. "Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey." Drug and Alcohol Dependence, vol. 105, no. 1-2, 2009, pp. 83-88. |
| McKenzie M, Nunn A, Zaller ND, Bazazi AR, Rich JD. "Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice." Journal of opioid management, vol. 5, no. 4, 2009, pp. 219-27. |
| Wakeman SE, Bowman SE, McKenzie M, Jeronimo A, Rich JD. "Preventing death among the recently incarcerated: an argument for naloxone prescription before release." Journal of addictive diseases, vol. 28, no. 2, 2009, pp. 124-9. |
| Spaete J, Patrozou E, Rich JD, Sweeney JD. "Red cell exchange transfusion for babesiosis in Rhode Island." Journal of clinical apheresis, vol. 24, no. 3, 2009, pp. 97-105. |
| Baillargeon, Jacques. "Treatment for Individuals With HIV/AIDS Following Release From Prison—Reply." JAMA, vol. 302, no. 2, 2009, pp. 147. |
| Chew KW, Allen SA, Taylor LE, Rich JD, Feller E. "Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C." Journal of clinical gastroenterology, vol. 43, no. 7, 2009, pp. 686-91. |
| Mitty JA, Bazerman LB, Selwyn K, Beckwith CG, Zaller ND, Rich JD. "Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island." The AIDS reader, vol. 18, no. 12, 2008, pp. 596-600. |
| Zaller ND, Holmes L, Dyl AC, Mitty JA, Beckwith CG, Flanigan TP, Rich JD. "Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge." Journal of Health Care for the Poor and Underserved, vol. 19, no. 2, 2008, pp. 522-31. |
| Wakeman, Sarah, Rich, Josiah. "Literature in Brief." Journal of Urban Health, vol. 86, no. 1, 2008, pp. 3-4. |
| Nijhawan A, Kim S, Rich JD. "Management of HIV infection in patients with substance use problems." Current Infectious Disease Reports, vol. 10, no. 5, 2008, pp. 432-8. |
| Bowman S, McKenzie M, Rich J. "Overdose prevention: naloxone with long acting opioids." Medicine and health, Rhode Island, vol. 91, no. 9, 2008, pp. 271-2. |
| Bonney LE, Clarke JG, Simmons EM, Rose JS, Rich JD. "Racial/ethnic sexual health disparities among incarcerated women." Journal of the National Medical Association, vol. 100, no. 5, 2008, pp. 553-8. |
| Pearson FS, Cleland CM, Chaple M, Hamilton Z, Prendergast ML, Rich JD. "Substance use, mental health problems, and behavior at risk for HIV: evidence from CJDATS." Journal of Psychoactive Drugs, vol. 40, no. 4, 2008, pp. 459-69. |
| Zaller N, Gillani FS, Rich JD. "A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness." AIDS Care, vol. 19, no. 9, 2007, pp. 1128-33. |
| Boutwell AE, Nijhawan A, Zaller N, Rich JD. "Arrested on heroin: a national opportunity." Journal of opioid management, vol. 3, no. 6, 2007, pp. 328-32. |
| Beckwith CG, Atunah-Jay S, Cohen J, Macalino G, Poshkus M, Rich JD, Flanigan TP, Lally MA. "Feasibility and acceptability of rapid HIV testing in jail." AIDS Patient Care and STDs, vol. 21, no. 1, 2007, pp. 41-7. |
| Rich, Josiah D. "Health Issues in Prisons and Jails." Journal of Urban Health, vol. 84, no. 6, 2007, pp. 740-741. |
| Rich, Josiah D. "Health Issues in Prisons and Jails: Implications for Urban Health." Journal of Urban Health, vol. 84, no. 3, 2007, pp. 316-318. |
| Zaller, Nickolas D., Taylor, Lynn E., Allen, Scott, Rich, Josiah D. "Hepatitis C in correctional institutions." Current Hepatitis Reports, vol. 6, no. 3, 2007, pp. 114-118. |
| McKenzie M, Rich JD. "Heroin in the corrections system: introduction." Medicine and health, Rhode Island, vol. 90, no. 5, 2007, pp. 140-1. |
| Beckwith CG, Cohen J, Shannon C, Raz L, Rich JD, Lally MA. "HIV testing experiences among male and female inmates in Rhode Island." The AIDS reader, vol. 17, no. 9, 2007, pp. 459-64. |
| Zaller N, Thurmond P, Rich JD. "Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners." public health reports, vol. 122, no. 1, 2007, pp. 49-54. |
| Rich JD, Hogan JW, Wolf F, DeLong A, Zaller ND, Mehrotra M, Reinert S. "Lower syringe sharing and re-use after syringe legalization in Rhode Island." Drug and Alcohol Dependence, vol. 89, no. 2-3, 2007, pp. 292-7. |
| Schwartz RP, McKenzie M, Rich JD. "Opioid addiction and incarceration: an overview." Medicine and health, Rhode Island, vol. 90, no. 5, 2007, pp. 157-8. |
| Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. "Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities." Journal of Urban Health, vol. 84, no. 1, 2007, pp. 126-36. |
| Allen SA, Rich JD. "Prisons and mental health." New England Journal of Medicine, vol. 356, no. 2, 2007, pp. 197-8. |
| Zaller N, Dawalt M, Beckwith C, Rich JD, Flanigan TP. "Routine HIV testing in US prisons." The Lancet Infectious Diseases, vol. 7, no. 7, 2007, pp. 440-1. |
| Tedeschi SK, Bonney LE, Manalo R, Mayer KH, Shepardson S, Rich JD, Lally MA. "Vaccination in juvenile correctional facilities: state practices, hepatitis B, and the impact on anticipated sexually transmitted infection vaccines." public health reports, vol. 122, no. 1, 2007, pp. 44-8. |
| Beckwith CG, Moreira CC, Aboshady HM, Zaller N, Rich JD, Flanigan TP. "A success story: HIV prevention for injection drug users in Rhode Island." Substance abuse treatment, prevention, and policy, vol. 1, 2006, pp. 34. |
| BECKWITH, CURT G., ZALLER, NICK, RICH, JOSIAH D. "ADDRESSING THE HIV EPIDEMIC THROUGH QUALITY CORRECTIONAL HEALTHCARE." Criminology Public Policy, vol. 5, no. 1, 2006, pp. 149-155. |
| Allen SA, Rich JD, Bux RC, Farbenblum B, Berns M, Rubenstein L. "Deaths of detainees in the custody of US forces in Iraq and Afghanistan from 2002 to 2005." MedGenMed : Medscape general medicine, vol. 8, no. 4, 2006, pp. 46. |
| Merchant RC, Schwartzapfel BL, Wolf FA, Li W, Carlson L, Rich JD. "Demographic, geographic, and temporal patterns of ambulance runs for suspected opiate overdose in Rhode Island, 1997-20021." Substance Use & Misuse, vol. 41, no. 9, 2006, pp. 1209-26. |
| Rich JD, Mitty JA, Beckwith CG. "Editorial comment: correctional opportunities to address the HIV/AIDS epidemic." The AIDS reader, vol. 16, no. 5, 2006, pp. 258. |
| Zaller ND, Thurmond P, Brett J, Carleton JC, Rich JD. "Linkage to methadone treatment from acute opiate detoxification treatment." Journal of opioid management, vol. 2, no. 6, 2006, pp. 341-6. |
| Rich, Josiah D., Strong, Larkin, Towe, Christopher W., McKenzie, Michelle. "Obstacles to Needle Exchange Participation in Rhode Island." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 21, no. 5, 2006, pp. 396. |
| Vallabhaneni S, Macalino GE, Reinert SE, Schwartzapfel B, Wolf FA, Rich JD. "Prisoners favour hepatitis C testing and treatment." Epidemiology and Infection, vol. 134, no. 2, 2006, pp. 243-8. |
| Mayer K, Rich J. "Sex, culture, and health: what doctors need to know." Medicine and health, Rhode Island, vol. 89, no. 6, 2006, pp. 194. |
| Rich JD, Anderson BJ, Schwartzapfel B, Stein MD. "Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users." Epidemiology and Infection, vol. 134, no. 3, 2006, pp. 478-84. |
| Rich JD, Ghazal M, Mansfield B, Ramsey S, Donnelly D. "Specialized STD care in Rhode Island." Medicine and health, Rhode Island, vol. 89, no. 6, 2006, pp. 212. |
| Lally M, Gaitanis M, Vallabhaneni S, Reinert S, Mayer K, Zimet G, Rich J. "Willingness to receive an HIV vaccine among incarcerated persons." Preventive Medicine, vol. 43, no. 5, 2006, pp. 402-5. |
| Macalino GE, Dhawan D, Rich JD. "A missed opportunity: hepatitis C screening of prisoners." American Journal of Public Health, vol. 95, no. 10, 2005, pp. 1739-40. |
| Boutwell AE, Rich JD. "Arrested, addicted: heroin users in the Rhode Island Corrections System." Medicine and health, Rhode Island, vol. 88, no. 12, 2005, pp. 421-3. |
| Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, Friedmann PD. "Attitudes and practices regarding the use of methadone in US state and federal prisons." Journal of Urban Health, vol. 82, no. 3, 2005, pp. 411-9. |
| Macalino GE, Vlahov D, Dickinson BP, Schwartzapfel B, Rich JD. "Community incidence of hepatitis B and C among reincarcerated women." Clinical Infectious Diseases, vol. 41, no. 7, 2005, pp. 998-1002. |
| Henry PC, Rich JD. "Editorial comment: the complexities of homelessness and HIV." The AIDS reader, vol. 15, no. 11, 2005, pp. 613. |
| Rich, J. D. "Health Issues in Prisons and Jails: Implications for Urban Health." Journal of Urban Health, vol. 82, no. 3, 2005, pp. 356-357. |
| Taylor LE, Gholam PM, Schwartzapfel B, Rich JD. "Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report." The AIDS reader, vol. 15, no. 11, 2005, pp. 629-31, 634-6, 638. |
| Spaete JP, Rich JD. "HIV prevention and care in incarcerated populations." Focus (San Francisco, Calif.), vol. 20, no. 8, 2005, pp. 1-5. |
| Rich JD, McKenzie M, Shield DC, Wolf FA, Key RG, Poshkus M, Clarke J. "Linkage with methadone treatment upon release from incarceration: a promising opportunity." Journal of addictive diseases, vol. 24, no. 3, 2005, pp. 49-59. |
| McKenzie M, Macalino G, McClung C, Shield DC, Rich JD. "Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program." Journal of opioid management, vol. 1, no. 3, 2005, pp. 147-51. |
| Boutwell AE, Allen SA, Rich JD. "Opportunities to address the hepatitis C epidemic in the correctional setting." Clinical Infectious Diseases, vol. 40 Suppl 5, 2005, pp. S367-72. |
| Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA. "Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users." Clinical Infectious Diseases, vol. 40 Suppl 5, 2005, pp. S276-85. |
| Zaller N, Noak A, Poshkus M, McDonald L, Rich JD. "The overlapping epidemics of viral hepatitis/HIV, addiction and incarceration: the situation in Rhode Island." Medicine and health, Rhode Island, vol. 88, no. 12, 2005, pp. 424-7. |
| Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, McNamara S, Mehrotra M, Stein MD. "A syringe prescription program to prevent infectious disease and improve health of injection drug users." Journal of Urban Health, vol. 81, no. 1, 2004, pp. 122-34. |
| Allen, Scott A., Spaulding, Anne C., Taylor, Lynn E., Rich, Josiah D. "Confined treatment continued." Gastroenterology, vol. 126, no. 3, 2004, pp. 928. |
| Allen SA, Spaulding AC, Taylor LE, Rich JD. "Confined treatment continued." Gastroenterology, vol. 126, no. 3, 2004, pp. 928. |
| Kwara A, Carter EJ, Rich JD, Flanigan TP. "Development of Opportunistic Infections After Diagnosis of Active Tuberculosis in HIV-Infected Patients." AIDS Patient Care and STDs, vol. 18, no. 6, 2004, pp. 341-7. |
| Rompalo AM, Shah N, Margolick JB, Farzadegan H, Arnsten J, Schuman P, Rich JD, Gardner LI, Smith DK, Vlahov D, HIV Epidemiology Research Study Group. "Evaluation of possible effects of continued drug use on HIV progression among women." International journal of STD & AIDS, vol. 15, no. 5, 2004, pp. 322-7. |
| Macalino, G.E, Hou, J.C, Kumar, M.S, Taylor, L.E, Sumantera, I.G, Rich, J.D. "Hepatitis C infection and incarcerated populations." International Journal of Drug Policy, vol. 15, no. 2, 2004, pp. 103-114. |
| Boutwell A, Rich JD. "HIV infection behind bars." Clinical Infectious Diseases, vol. 38, no. 12, 2004, pp. 1761-3. |
| "Literature in Brief." Journal of Urban Health, vol. 81, no. 1, 2004, pp. 3-13. |
| "Literature in Brief." Journal of Urban Health, vol. 81, no. 2, 2004, pp. 172-178. |
| "Literature in Brief." Journal of Urban Health, vol. 81, no. 4, 2004, pp. 525-526. |
| Taylor LE, Rich JD, Tashima KT. "Peginterferon plus ribavirin for hepatitis C in HIV-infected patients." New England Journal of Medicine, vol. 351, no. 22, 2004, pp. 2340-2; author reply 2340-2. |
| Stozek MA, Taylor LE, LeBreux L, Olson J, Wolf F, Rich JD. "Prescribing syringes to injection drug users with HIV: an important clinical and public health tool." Journal of the Association of Nurses in AIDS Care, vol. 15, no. 2, 2004, pp. 59-63. |
| Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. "Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons." American Journal of Public Health, vol. 94, no. 7, 2004, pp. 1218-23. |
| Vallabhaneni S, Macalino GE, Reinert SE, Schwartzapfel B, Wolf FA, Rich JD. "Prisoners' attitudes toward Hepatitis B vaccination." Preventive Medicine, vol. 38, no. 6, 2004, pp. 828-33. |
| Rich, Josiah D. "Screening for Hepatitis C Virus Infection in Adults." Annals of Internal Medicine, vol. 141, no. 7, 2004, pp. 575. |
| Rich JD, Taylor LE, Allen SA. "Screening for hepatitis C virus infection in adults." Annals of Internal Medicine, vol. 141, no. 7, 2004, pp. 575-6; author reply 576. |
| Boutwell A, Rich JD. "Syringe access for injection drug users in Rhode Island." Medicine and health, Rhode Island, vol. 87, no. 1, 2004, pp. 15-6. |
| Rich JD, Ching CG, Lally MA, Gaitanis MM, Schwartzapfel B, Charuvastra A, Beckwith CG, Flanigan TP. "A review of the case for hepatitis B vaccination of high-risk adults." The American Journal of Medicine, vol. 114, no. 4, 2003, pp. 316-8. |
| Macalino GE, Ko H, Celentano DD, Hogan JW, Schoenbaum EE, Schuman P, Rich JD, HER Study Group. "Drug use patterns over time among HIV-seropositive and HIV-seronegative women: the HER study experience." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 4, 2003, pp. 500-5. |
| Clarke J, Schwartzapfel B, Pomposelli J, Allen S, Spaulding A, Rich JD. "Hepatitis B vaccination of incarcerated women: a pilot program." Journal of Health Care for the Poor and Underserved, vol. 14, no. 3, 2003, pp. 318-23. |
| Rich JD, Taylor L, Mehrotra M, Mason R, Stozek M, Stancliff S. "Prescribing syringes to injection drug users: what the family physician should know." American family physician, vol. 68, no. 1, 2003, pp. 45-7. |
| Stancliff S, Agins B, Rich JD, Burris S. "Syringe access for the prevention of blood borne infections among injection drug users." BMC Public Health, vol. 3, 2003, pp. 37. |
| Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD. "Treatment of chronic hepatitis C in a state correctional facility." Annals of Internal Medicine, vol. 138, no. 3, 2003, pp. 187-90. |
| Taylor LE, Runarsdottir V, Zampi A, Osei A, Sanford S, Macalino G, McKenzie M, Burris S, Gross JD, Reinert SE, Rich JD. "Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey." Journal of addictive diseases, vol. 22, no. 1, 2003, pp. 67-78. |
| Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE, HER Study Group. "A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women." AIDS, vol. 16, no. 16, 2002, pp. 2175-82. |
| Rich JD, Macalino G, Merchant RC, Salas C, Marcussen P, Grundy M, Spaulding A. "HIV seroprevalence of adult males incarcerated for a sexual offense in Rhode Island, 1994-1999." JAMA, vol. 288, no. 2, 2002, pp. 164-5. |
| Berzin T, Allen S, Taylor L, Rich J, Feller E. "Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections." Medicine and health, Rhode Island, vol. 85, no. 11, 2002, pp. 341-4. |
| Feller AA, Mylonakis E, Rich JD. "Medical complications of anabolic steroids." Medicine and health, Rhode Island, vol. 85, no. 11, 2002, pp. 338-40. |
| Rich JD, Martin EG, Macalino GE, Paul RV, McNamara S, Taylor LE. "Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island." Journal of the American Pharmaceutical Association (Washington,D.C. : 1996), vol. 42, no. 6 Suppl 2, 2002, pp. S58-61. |
| Merchant RC, Mayer KH, Rich JD. "Prophylactic panic." AIDS clinical care, vol. 14, no. 6, 2002, pp. 55. |
| Rich JD, Wolf FA, Macalino G. "Strategies to improve access to sterile syringes for injection drug users." The AIDS reader, vol. 12, no. 12, 2002, pp. 527-35. |
| Desai AA, Latta ET, Spaulding A, Rich JD, Flanigan TP. "The importance of routine HIV testing in the incarcerated population: the Rhode Island experience." AIDS Education and Prevention, vol. 14, no. 5 Suppl B, 2002, pp. 45-52. |
| Crosland C, Poshkus M, Rich JD. "Treating prisoners with HIV/AIDS: the importance of early identification, effective treatment, and community follow-up." AIDS clinical care, vol. 14, no. 8, 2002, pp. 67-71, 76. |
| Cannon MJ, Dollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahov D, Pellett PE, HIV Epidemiology Research Study Group. "Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection." New England Journal of Medicine, vol. 344, no. 9, 2001, pp. 637-43. |
| Mileno MD, Barnowski C, Fiore T, Gormley J, Rich JD, Emgushov RT, Carpenter CC. "Factitious HIV syndrome in young women." The AIDS reader, vol. 11, no. 5, 2001, pp. 278-82. |
| Charuvastra A, Stein J, Schwartzapfel B, Spaulding A, Horowitz E, Macalino G, Rich JD. "Hepatitis B vaccination practices in state and federal prisons." public health reports, vol. 116, no. 3, 2001, pp. 203-9. |
| Pugatch D, Strong LL, Has P, Patterson D, Combs C, Reinert S, Rich JD, Flanigan T, Brown L. "Heroin use in adolescents and young adults admitted for drug detoxification." Journal of substance abuse, vol. 13, no. 3, 2001, pp. 337-46. |
| Thomas DL, Rich JD, Schuman P, Smith DK, Astemborski JA, Nolt KR, Klein RS. "Multicenter evaluation of hepatitis C RNA levels among female injection drug users." The Journal of Infectious Diseases, vol. 183, no. 6, 2001, pp. 973-6. |
| Mylonakis E, Paliou M, Rich JD. "Plasma viral load testing in the management of HIV infection." American family physician, vol. 63, no. 3, 2001, pp. 483-90, 495-6. |
| Rich JD, Whitlock TL, Towe CW, McKenzie M, Runarsdottir V, Aboagye-Kumi M, Burris S. "Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island." Substance Use & Misuse, vol. 36, no. 5, 2001, pp. 535-50. |
| Rich JD, Hou JC, Charuvastra A, Towe CW, Lally M, Spaulding A, Bandy U, Donnelly EF, Rompalo A. "Risk factors for syphilis among incarcerated women in Rhode Island." AIDS Patient Care and STDs, vol. 15, no. 11, 2001, pp. 581-5. |
| Rich JD, Holmes L, Salas C, Macalino G, Davis D, Ryczek J, Flanigan T. "Successful linkage of medical care and community services for HIV-positive offenders being released from prison." Journal of Urban Health, vol. 78, no. 2, 2001, pp. 279-89. |
| Rich JD, Macalino GE, McKenzie M, Taylor LE, Burris S. "Syringe prescription to prevent HIV infection in Rhode Island: a case study." American Journal of Public Health, vol. 91, no. 5, 2001, pp. 699-700. |
| Rich JD, McKenzie M, Macalino G, Runnarsdottir V, Gaydos M, Mehrotra M, Stein J, Whitlock T, Salas C, Burris S. "The genesis of syringe prescription to prevent HIV in Rhode Island." Health matrix (Cleveland, Ohio : 1991), vol. 11, no. 1, 2001, pp. 129-45. |
| Stein MD, Rich JD, Maksad J, Chen MH, Hu P, Sobota M, Clarke J. "Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use." The American Journal of Drug and Alcohol Abuse, vol. 26, no. 2, 2000, pp. 195-205. |
| Stein MD, Hanna L, Natarajan R, Clarke J, Marisi M, Sobota M, Rich J. "Alcohol use patterns predict high-risk HIV behaviors among active injection drug users." Journal of Substance Abuse Treatment, vol. 18, no. 4, 2000, pp. 359-63. |
| Mylonakis E, Paliou M, Sax PE, Skolnik PR, Baron MJ, Rich JD. "Central nervous system aspergillosis in patients with human immunodeficiency virus infection. Report of 6 cases and review." Medicine, vol. 79, no. 4, 2000, pp. 269-80. |
| Farley JL, Mitty JA, Lally MA, Burzynski JN, Tashima K, Rich JD, Cu-Uvin S, Spaulding A, Normandie L, Snead M, Flanigan TP. "Comprehensive Medical Care among HIV-Positive Incarcerated Women: The Rhode Island Experience." Journal of women's health & gender-based medicine, vol. 9, no. 1, 2000, pp. 51-6. |
| Farley JL, Mitty JA, Lally MA, Burzynski JN, Tashima K, Rich JD, Cu-Uvin S, Spaulding A, Normandie L, Snead M, Flanigan TP. "Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience." Journal of Women's Health and Gender Based Medicine, vol. 9, no. 1, 2000, pp. 51-6. |
| Rich JD, Foisie CK, Towe CW, McKenzie M, Salas CM. "High street prices of syringes correlate with strict syringe possession laws." The American Journal of Drug and Alcohol Abuse, vol. 26, no. 3, 2000, pp. 481-7. |
| Mylonakis E, Paliou M, Lally M, Flanigan TP, Rich JD. "Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches." The American Journal of Medicine, vol. 109, no. 7, 2000, pp. 568-76. |
| Burris S, Lurie P, Abrahamson D, Rich JD. "Physician prescribing of sterile injection equipment to prevent HIV infection: time for action." Annals of Internal Medicine, vol. 133, no. 3, 2000, pp. 218-26. |
| Mylonakis E, Paliou M, Greenbough TC, Flaningan TP, Letvin NL, Rich JD. "Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus." Arch Intern Med, vol. 160, no. 15, 2000, pp. 2386-8. |
| Rich JD, Strong LL, Mehrotra M, Macalino G. "Strategies to optimize the impact of needle exchange programs." The AIDS reader, vol. 10, no. 7, 2000, pp. 421-9. |
| Rich JD, Dickinson BP, Flanigan TP, Valone SE. "Abscess related to anabolic-androgenic steroid injection." Medicine & Science in Sports & Exercise, vol. 31, no. 2, 1999, pp. 207-9. |
| Spaulding AC, Lally M, Rich JD, Dieterich DT. "Hepatitis B and C in the context of HIV disease: implications for incarcerated populations." The AIDS reader, vol. 9, no. 7, 1999, pp. 481-91. |
| Spaulding A, Greene C, Davidson K, Schneidermann M, Rich J. "Hepatitis C in state correctional facilities." Preventive Medicine, vol. 28, no. 1, 1999, pp. 92-100. |
| Rich JD, Mylonakis E, Nossa R, Chapnick RM. "Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C." Digestive Diseases and Sciences, vol. 44, no. 5, 1999, pp. 1034-7. |
| Flanigan TP, Rich JD, Spaulding A. "HIV care among incarcerated persons: a missed opportunity." AIDS, vol. 13, no. 17, 1999, pp. 2475-6. |
| Rich JD, Dickinson BP, Flaxman AB, Mylonakis E. "Local spread of molluscum contagiosum by electrolysis." Clinical Infectious Diseases, vol. 28, no. 5, 1999, pp. 1171. |
| Willy RJ, Salas CM, Macalino GE, Rich JD. "Long-term non-progression of HIV-1 in a patient coinfected with HTLV-II." Diagnostic microbiology and infectious disease, vol. 35, no. 4, 1999, pp. 269-70. |
| Rich JD, Merriman NA, Mylonakis E, Greenough TC, Flanigan TP, Mady BJ, Carpenter CC. "Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series." Annals of Internal Medicine, vol. 130, no. 1, 1999, pp. 37-9. |
| Rich JD, Foisie CK, Towe CW, Dickinson BP, McKenzie M, Salas CM. "Needle exchange program participation by anabolic steroid injectors, United States 1998." Drug and Alcohol Dependence, vol. 56, no. 2, 1999, pp. 157-60. |
| Rich JD, Strong L, Towe CW, McKenzie M. "Obstacles to needle exchange participation in Rhode Island." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 21, no. 5, 1999, pp. 396-400. |
| Mylonakis E, Dickinson BP, Mileno MD, Flanigan T, Schiffman FJ, Mega A, Rich JD. "Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy." American Journal of Hematology, vol. 60, no. 2, 1999, pp. 164-6. |
| Dickinson BP, Mylonakis E, Strong LL, Rich JD. "Potential infections related to anabolic steroid injection in young adolescents." Pediatrics, vol. 103, no. 3, 1999, pp. 694. |
| Rich JD, Dickinson BP, Macalino G, Flanigan TP, Towe CW, Spaulding A, Vlahov D. "Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 22, no. 2, 1999, pp. 161-6. |
| Vigilante KC, Flynn MM, Affleck PC, Stunkle JC, Merriman NA, Flanigan TP, Mitty JA, Rich JD. "Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning." Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research, vol. 8, no. 3, 1999, pp. 409-15. |
| Chodock R, Mylonakis E, Shemin D, Runarsdottir V, Yodice P, Renzi R, Tashima K, Towe C, Rich JD. "Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment." Nephrol. Dial. Transplant., vol. 14, no. 10, 1999, pp. 2484-6. |
| Rich JD, Dickinson BP, Feller A, Pugatch D, Mylonakis E. "The infectious complications of anabolic-androgenic steroid injection." International journal of sports medicine, vol. 20, no. 8, 1999, pp. 563-6. |
| Mylonakis E, Merriman NA, Rich JD, Flanigan TP, Walters BC, Tashima KT, Mileno MD, van der Horst CM. "Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis." Diagnostic microbiology and infectious disease, vol. 34, no. 2, 1999, pp. 111-4. |
| Mylonakis E, Dickinson B, Feller A, Sweeney J, Schiffman FJ, Rich J, Flanigan T. "Combination antiretroviral therapy including a protease inhibitor eliminated the transfusion requirements of HIV-infected individuals with anemia of chronic disease." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 19, no. 3, 1998, pp. 306-7. |
| Rich JD, Dickinson BP, Carney JM, Fisher A, Heimer R. "Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection." AIDS, vol. 12, no. 17, 1998, pp. 2345-50. |
| Rich JD, Dickinson BP, Merriman NA, Flanigan TP. "Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter." American Journal of Gastroenterology, vol. 93, no. 9, 1998, pp. 1598. |
| Rich JD, Dickinson BP, Merriman NA, Thule PM. "Insulin use by bodybuilders." JAMA, vol. 279, no. 20, 1998, pp. 1613. |
| Rich JD, Dickinson BP, Spaulding A, Lafazia L, Flanigan TP. "Interpretation of indeterminate HIV serology results in an incarcerated population." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 17, no. 4, 1998, pp. 376-9. |
| Pugatch D, Mileno M, Rich JD. "Possible transmission of human immunodeficiency virus type 1 from body piercing." Clinical Infectious Diseases, vol. 26, no. 3, 1998, pp. 767-8. |
| Dickinson BP, Mitty JA, Mylonakis E, Rich JD, Merriman NA, Tashima KT, Carpenter CC, Flanigan TP. "Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care." AIDS, vol. 12, no. 15, 1998, pp. 2075-6. |
| Mylonakis E, Barlam TF, Flanigan T, Rich JD. "Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases." Chest, vol. 114, no. 1, 1998, pp. 251-62. |
| Mylonakis E, Mileno MD, Flanigan T, De Orchis DF, Rich J. "Pulmonary invasive aspergillosis in patients infected with the human immunodeficiency virus: report of two cases." Heart & Lung: The Journal of Acute and Critical Care, vol. 27, no. 1, 1998, pp. 63-6. |
| Rich JD, Dickinson BP, Liu KL, Case P, Jesdale B, Ingegneri RM, Nolan PA. "Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 18 Suppl 1, 1998, pp. S140-1. |
| Mylonakis E, Koutkia P, Rich JD, Tashima KT, Fiore TC, Flanigan T, Carpenter CC. "Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA." AIDS, vol. 12, no. 8, 1998, pp. 958-9. |
| Rich JD, Dokson L, Dickinson BP. "The economic cost of strict syringe control." Medicine and health, Rhode Island, vol. 81, no. 6, 1998, pp. 207-8. |
| Rich JD, Chin-Hong PV, Busi KA, Mayer KH, Flanigan TP. "Hepatitis C and HIV in male prisoners." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 16, no. 5, 1997, pp. 408-9. |
| Rich JD, Nizam R, Das K, Islam S, Akhtar N, Dickinson BP, Flanigan TP, Mayer K, Carpenter CC. "HIV and syphilis prevalence in chittagong, Bangladesh." AIDS, vol. 11, no. 5, 1997, pp. 703-4. |
| Pugatch D, Rich JD, Flanigan TP. "HIV infection in Rhode Island adolescents." Medicine and health, Rhode Island, vol. 80, no. 10, 1997, pp. 331-3. |
| Mylonakis E, Rich J, Skolnik PR, De Orchis DF, Flanigan T. "Invasive Aspergillus sinusitis in patients with human immunodeficiency virus infection. Report of 2 cases and review." Medicine, vol. 76, no. 4, 1997, pp. 249-55. |
| Rich JD, Ramratnam B, Chiang M, Tashima KT. "Management of indinavir associated nephrolithiasis." The Journal of Urology, vol. 158, no. 6, 1997, pp. 2228. |
| Rich JD, Sullivan T, Greineder D, Kazanjian PH. "Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons." Annals of Allergy, Asthma & Immunology, vol. 79, no. 5, 1997, pp. 409-14. |
| Rich JD, Ramratnam B, Flanigan TP. "Triple combination antiretroviral prophylaxis for needlestick exposure to HIV." Infection Control & Hospital Epidemiology, vol. 18, no. 3, 1997, pp. 161. |
| Farrar DJ, Flanigan TP, Gordon NM, Gold RL, Rich JD. "Tuberculous brain abscess in a patient with HIV infection: case report and review." The American Journal of Medicine, vol. 102, no. 3, 1997, pp. 297-301. |
| Flanigan TP, Kim JY, Zierler S, Rich J, Vigilante K, Bury-Maynard D. "A prison release program for HIV-positive women: linking them to health services and community follow-up." American Journal of Public Health, vol. 86, no. 6, 1996, pp. 886-7. |
| Rich JD. "Autoimmune hepatitis." New England Journal of Medicine, vol. 335, no. 10, 1996, pp. 753. |
| Joste NE, Rich JD, Busam KJ, Schwartz DA. "Autopsy verification of Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy." Archives of Pathology & Laboratory Medicine, vol. 120, no. 2, 1996, pp. 199-203. |
| Rich JD, Mirochnick M. "Dapsone penetrates cerebrospinal fluid during Pneumocystis carinii pneumonia prophylaxis." Diagnostic microbiology and infectious disease, vol. 24, no. 2, 1996, pp. 77-9. |
| Cu-Uvin S, Flanigan TP, Rich JD, Mileno MD, Mayer KH, Carpenter CC. "Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women." The American Journal of Medicine, vol. 101, no. 3, 1996, pp. 316-22. |
| Elliot BC, Rogers M, Rich JD. "Indeterminate results of HIV testing: explanation and clinical management." Medicine and health, Rhode Island, vol. 79, no. 10, 1996, pp. 360-2. |
| Mylonakis E, Rich JD, Flanigan T, Kwakwa H, De Orchis DF, Boyce J, Mileno MD. "Muscle abscess due to Aspergillus fumigatus in a patient with AIDS." Clinical Infectious Diseases, vol. 23, no. 6, 1996, pp. 1323-4. |
| Lewis DC, Rich JD. "Physicians should support needle exchange in Rhode Island." Medicine and health, Rhode Island, vol. 79, no. 6, 1996, pp. 206. |
| Ramratnam B, Parameswaran J, Elliot B, Newstein M, Schiffman FJ, Rich JD, Flanigan TP. "Short course dexamethasone for thrombocytopenia in AIDS." The American Journal of Medicine, vol. 100, no. 1, 1996, pp. 117-8. |
| Flanigan TP, Uvin SC, Rich JD, Mileno MD, Vigilante K, Tashima K. "Update of HIV and AIDS in North America." Medicine and health, Rhode Island, vol. 79, no. 5, 1996, pp. 180-7. |
| Sax PE, Rich JD, Pieciak WS, Trnka YM. "Intestinal microsporidiosis occurring in a liver transplant recipient." Transplantation, vol. 60, no. 6, 1995, pp. 617-8. |
| Rich JD, Sax PE, Kazanjian PH. "Bacteremic H. influenzae type b infections and HIV." The American Journal of Medicine, vol. 95, no. 1, 1993, pp. 118-9. |
| DeMuria D, Forrest A, Rich J, Scavone JM, Cohen LG, Kazanjian PH. "Pharmacokinetics and bioavailability of fluconazole in patients with AIDS." Antimicrobial Agents and Chemotherapy, vol. 37, no. 10, 1993, pp. 2187-92. |
| Rich JD, Buck A, Tuomala RE, Kazanjian PH. "Transmission of human immunodeficiency virus infection presumed to have occurred via female homosexual contact." Clinical Infectious Diseases, vol. 17, no. 6, 1993, pp. 1003-5. |
| Rich JD, Crawford JM, Kazanjian SN, Kazanjian PH. "Discrete gastrointestinal mass lesions caused by cytomegalovirus in patients with AIDS: report of three cases and review." Clinical Infectious Diseases, vol. 15, no. 4, 1992, pp. 609-14. |
| Rich JD. "Transdermal nicotine patch for smoking cessation." New England Journal of Medicine, vol. 326, no. 5, 1992, pp. 344-5. |
GRANTS, ACTIVE
1. Integrating Long-Acting Injectable Treatment to Improve Medication Adherence Among Persons Living With HIV and Opioid Use Disorder-NIH-1R34DA055498-01 Principle Investigator: Langdon, K. Principle Investigator: Rich, J.D. 4/01/2022 – 2/28/2025: $691,534
2. Preventing Overdose Involving Stimulants (POINTS) Study Brown/CDC- 1R01CE003353-01-00 Principle Investigator: White Hughto, Co-Investigator: J. Rich, J.D. MD, MPH 9/30/2021 – 9/29/2024: $362,499
3. Using Implementation Interventions and Peer Recovery Support to Improve Opioid Treatment Outcomes in Community Supervision(MOUD)-1U01DA050442-01 Principle Investigator: Martin 08/01/2019 - 04/30/2024 $2,083,986
4. Navigating the Fentanyl Age with Community Drug Checking- NIH1-1UG3DA056881 Principle Investigator: Green, T Co-Investigator: Rich, J.D. 09/01/2022 – 07/31/2024: $381,649
5. Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island- NIH/NIDA-1R21DA057171 Principle Investigator: Del Pozo, B. Principle Investigator: Rich, J.D.8/15/2022-7/31/2024: $444,693
6. The Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS): Responding to Fentanyl and Associated Harms- National Institutes on Drug Abuse 1R01DA0479795-01 Principal Investigator: Marshall, Co-Investigator: Rich, Josiah MD, MPH 8/15/2019-5/31/2024: $751,010
7. Cobre Center On Opioids and Overdose- National Institutes of Health- P20GM125507 Principal Investigator/RIH: Rich, Josiah, MD, MPH 9/07/2023 - 8/31/2028 $12,071,270
8. Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation- National Instututes on Drug Abuse R01DA059469-01 Principal Investigator: Carskadon M. Mcgeary J. Rich JD, MD MPH 09/30/2023 - 08/31/2027 $4,302,854
GRANTS TRANSFERRED TO OTHER PRINCIPAL INVESTIGATORS
1. Ryan White Part B - Comprehensive HIV CARE Act Funded Health Care and Support Services for Rhode Islanders Living with HIV/AIDS HRSA/Rhode Island Department of Health -75H00214316 Principal Investigator: Rich, Josiah, MD, MPH (1994-2010) Principal Investigator: Kojic, Erna Milu, MD (2010-1/1/16) Principal Investigator: Garland, Joseph, MD 1/1/16 - 4/1/2007 – Current
2. Ryan White Part C - Outpatient Early Intervention Services with Respect to HIV Disease DHHS/Health Resources and Services Administration - 5H76HA00018 Principal Investigator: Rich, Josiah, MD, MPH (1994-2010) Principal Investigator: Montague, Brian, DO (2010-6/8/15) Principal Investigator: Rich, Josiah, MD, MPH (6/8/15-1/1/16) Principal Investigator: Garland, MD 1/1/16 - 05/01/1994 – Current
GRANTS, COMPLETED
1. A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care National Institutes of Health/National Institute on Drug Abuse - R01DA030771 Principal Investigator: Rich, Josiah, MD, MPH 08/01/2009 - 05/31/2015
2. Prisoner Overdose Prevention Training and Naloxone Upon Release National Institutes of Health/National Institute on Drug Abuse - R21DA029201-01A1 Principal Investigator: Rich, Josiah, MD, MPH 04/01/2010 - 06/30/2013
3. New HIV Diagnosis Occurring at the Rhode Island Department of Corrections, 2000-2007 (concurrent with parent R01DA027211) National Institutes of Health/National Institute on Drug Abuse - R01DA27211-01S1 Principal Investigator: Rich, Josiah, MD, MPH (2009-2011) Principal Investigator: Beckwith, Curt, MD (2011-2012) 12/01/2009-2/29/2012
4. Ryan White Part C - HIV Early Intervention Services (EIS) Program/Ongoing Expansion Funds for Current Part C Grantees Health Resources & Services Administration – 376HA00018 Principal Investigator: Rich, Josiah, MD, MPH (1994-2010) Principal Investigator: Montague, Brian, DO (2010-2011) 01/01/2010 - 12/31/2011
5. Ryan White Part C - Capacity Building Health Resources and Services Administration - H97HA15310 Principal Investigator: Rich, Josiah, MD, MPH (1994-2010) Principal Investigator: Brian Montague, DO (2010-2011) 09/01/2009 - 08/31/2011
6. Closing the Addiction Treatment Gap Initiative Open Society Institute (OSI) - 20023067 Principal Investigator: Rich, Josiah, MD, MPH (2008-2010) Principal Investigator: Zaller, Nickolas, Ph.D. (2010 - 2011) 09/01/2008 - 08/31/2011
7. Improving Ethics in Research: The Development of the Coercion Assessment Scale National Institutes of Health – R01DA025687 (Concurrent with R01DA027211) Principal Investigator: Dugash Co-Investigator: Rich, Josiah, MD, MPH 03/01/2011 - 02/29/2012
8. Feasibility of Pharmacy-Based HIV Interventions Among IDUs: 2 New England Cities National Institutes of Health/National Institute on Drug Abuse/Fenway Community Health Center - R21DA025010 Principal Investigator: Case, Patricia, PhD Co-Investigator: Rich, Josiah, MD, MPH 08/01/2009 - 07/31/2011: $32,811
9. Opiate Replacement Therapy at Release from Incarceration (ROMEO) National Institutes of Health/National Institute on Drug Abuse - R01DA018641 Principal Investigator: Rich, Josiah, MD, MPH 06/15/2005 - 03/31/2011
10. Ryan White Part C Capacity Development Health Resources and Services Administration - P06HA11136 Principal Investigator: Rich, Josiah, MD, MPH 09/01/2009 - 08/31/2010
11. Brief Intervention for Drug Misuse for the Emergency Department (BIDMED) National Institutes of Health/RIH Subcontract - R01DA026066 Principal Investigator: Merchant, Roland Clay, MD Co-Investigator: Rich, Josiah, MD, MPH 03/15/2009 - 02/28/2010
12. Outreach and Methadone for Former Prisoners (MOD) CSAT/SAMHSA – 6H79TI14562 Principal Investigator: Michelle McKenzie, MD, MPH Co-Investigator: Rich, Josiah, MD, MPH 10/01/2003 - 09/30/2008
13. Substance Abuse Treatment and HIV/AIDS Services (VISTA) CSAT/SAMHSA - H79TI15875 Principal Investigator: Rich, Josiah, MD, MPH 09/30/2003 - 09/29/2008
14, Continuity of Care for Drug-Addicted Offenders in Rhode Island National Institute on Drug Abuse - U01DA016191 Principal Investigator: Friedmann, Peter, MD, MPH Co-Investigator: Rich, Josiah, MD, MPH 09/25/2002 - 08/31/2008
15. Rationale Opiate Treatment Policies for Incarcerated Populations Soros Advocacy Fellowship for Physicians Medicine as a Profession (MAP) Open Society Institute (OSI) Grant Numbers: 10007246 and 20012153 Principal Investigator: Rich, Josiah, MD, MPH 07/01/2004 – 06/30/2007
16. A Trial to Reduce Hepatitis C Among Injection Drug Users RIH - R01DA123759 Principal Investigator: Stein, Michael, MD/MPH Co-Investigator: Rich, Josiah, MD, MPH 10/01/2001 - 08/31/2005
17. Access to HIV/HCV Prevention After Syringe Law Change (Sapphire) Study BROWN - R01DA14853 Principal Investigator: Macalino, Grace, PhD Co-Investigator: Rich, Josiah, MD, MPH 09/1/2002 - 08/31/04
18. HIV Prevention Trials Network (PTN) FENWAY - U01AI48040 Principal Investigator: Mayer, Kenneth, MD, MPH Co-Investigator: Rich, Josiah, MD, MPH 07/01/2000 - 06/30/2004
19. Hepatitis B Vaccination of Prisoners The Center for Disease Control and Prevention - U50CCU119078 Principal Investigator: Rich, Josiah, MD, MPH 09/30/2000 - 03/31/2004
20. Division of AIDS Research and Treatment Initiative The National Institutes of Health, NIAID - (DATRI)-002, N01AI15123 Principal Investigator: Josiah D. Rich, MD, MPH 1993 - 1997
21. A Randomized Trial of a Brief Alcohol Intervention for Needle Exchange Clients The National Institutes of Health - R01AA-DA11796 Principal Investigator: Michael Stein, MD Co-Investigator: Josiah D. Rich, MD, MPH 09/01/1998 - 08/31/1999
22. Prescription Syringe: Increasing Injection Drug Users Access to Sterile Needles Open Society Institute - 282941581 Principal Investigator: Josiah D. Rich, MD, MPH 12/16/1998 - 12/15/1999
23. Health Care Utilization Among Injection Drug Users The National Institutes of Health - RO1DA10567 Principal Investigator: Michael Stein, M.D. Co-Investigator: Josiah D. Rich, MD, MPH 04/01/1997 - 03/31/2000
24. An Evaluation of Physician Syringe Prescription to Prevent HIV Infection American Foundation for AIDS Research (AMFAR) - 10630-26-EG Principal Investigator: Josiah D. Rich, MD, MPH 05/01/1999 - 04/30/2000
25. Blood-borne Infections Among Imprisoned Drug Users The Center for Disease Control and Prevention/Johns Hopkins University U64-CCU314392 Principal Investigator: David Vlahov, M.D. Co-Investigator: Josiah D. Rich, MD, MPH 02/01/1998 - 06/30/2000
26. Utilization and Outcome of Needle Exchange in Women IDUs National Institutes of Health/National Institute on Drug Abuse - K20DA00268 Principal Investigator: Josiah D. Rich, MD, MPH 07/15/1995 - 06/30/2002
27. Comparing Medication Maintenance in Comprehensive Community and Pharmacy Setting to Enhance Engagement-National Institutes of Drug Abuse 4R33DA045848-02 Principal Investigator/RIH: Green, Traci Principal Investigator: Rich, Josiah MD, MPH 2/1/2019-12/31/2021
28. HIV and other Infectious Consequences of Substance Abuse- National Institutes on Drug Abuse - 2T32DA013911 Principal Invesitgator: Flanigan, Timothy, MD Co-Investigator: Rich, Josiah, MD, MPH 7/1/2001-6/30/2022 $204,593
29. Implementation to Motivate Physician Response to Opiod Depenedence in HIV Setting- National Institutes of Health- R01DA038082 Prinicpal Investigator/RIH: Friedman, Peter, MD Principal Investigator/TMH Rich, Josiah, MD, MPH 7/1/2001-6/30/2022 $68,428
30. Cobre Center On Opioids and Overdose- National Institutes of Health- P20GM125507 Principal Investigator/RIH: Rich, Josiah, MD, MPH 9/2018 - 8/2023 $11,811,586
1. Fourth Annual New England Maternal Outreach Institute (March of Dimes). Cromwell, CT. June 26, 1995.
2. National Youth Leadership Forum on Medicine, HIV/AIDS: A multidimensional perspective. "HIV/AIDS: The Race Against Time - Panel Discussion." Presented to high school juniors and seniors. Boston, Massachusetts. August 4, 1995.
3. Fifth Annual Ryan White CARE Act Title III(b) National Conference of All Title III (b) Grantees. Case Presentations. Washington, D.C. August 8, 1995.
4. Greater Fall River Physicians' CME Program. "HIV: Current Issues." Fall River, Massachusetts. September 26, 1995.
5. Second Annual New England HIV and Prisons Conference: "Clinical Trials in Correctional Institutions." Springfield, Massachusetts. October 20, 1995.
6. Quarterly Education Conference, presented by United Correctional Managed Care, Inc. and the New York State Department of Correctional Services: "Comprehensive Care of HIV Infected Prisoners." Syracuse, New York. March 19, 1996.
7. National Institutes of Health, Primary HIV Infection Workshop. Berkeley Springs, WV. April 18-19,1996.
8. Women Offenders in Transition Conference. Panel discussion: "Medical Costs and Health Concerns." Warwick, RI. April 23, 1996.
9. Rhode Island Project AIDS Medical Advisory Board. "Needle Exchange in Rhode Island." Providence, RI. May 20, 1996.
10. University of Rhode Island, College of Pharmacy. Spring Mini-Course Series. Managing Infection: Current Strategies in HIV. "Preventing Injection-Related Transmission of HIV." Warwick, RI. June 10, 1996.
11. New England Regional Conference on HIV Infection Among Incarcerated Women. Panelist. Providence, RI. November 5, 1997.
12. RI Society of Hospital Pharmacists/RI Pharmacists Association Annual Meeting. Guest Speaker, “Pharmacist’s Role in HIV Prevention.” North Kingston, RI. December 4, 1997.
13. Invited Speaker, “Legislative Removal of Syringe Control to Prevent the Spread of HIV. ”The American Medical Association’s Annual State Health Legislation Meeting, Orlando Florida. January 1998.
14. Invited Presentation, “Basics of HIV and Opportunistic Infections Commonly Seen in HIV Patients.” Lemuel Shattuck Hospital, Jamaica Plains, MA, July 19, 1998.
15. Grand Rounds at Winthrop-University Hospital, Long Island, NY, October, 1998.
16. AIDS Project Rhode Island. Keynote address, “HIV and Injection Drug Use in Rhode Island.” Providence, RI. November 4, 1998.
17. American Public Health Association’s 126th Annual Meeting and Exposition (accepted presentation). “Prevalence and Community Incidence of Bloodborne Pathogens in Incarcerated Women in Rhode Island.” Washington, DC. November, 15-18,1998.
18. Invited Presentation, “Syringe Prescription to Prevent the Spread of HIV.” 1999 National HIV prevention Conference, Atlanta, GA, August 29-September 1, 1999 (abstract no. 611).
19. Invited Speaker, “Physician Syringe Prescription for Injection Drug Users.” Brown/Division of General Internal Medicine Research Meeting, Providence, RI, June 17,1999.
20. Invited Presentation, “Exchange, Distribution or Sale? Strategies for Syringe Availability.” Open Society Institute, The Lindesmith Center, New York, NY, June 23,1999.
21. Invited Presentation, “Management of HIV/AIDS in the Correctional Setting: A Live, Satellite Videoconference Series.” Antiretroviral Update for the Next Millennium, Albany Medical Center, Albany, NY, October 12,1999.
22. Invited Speaker, “Life and Research Behind Bars: Our Work at the ACI.” Brown University School of Medicine, Providence, RI, October 21,1999.
23. Invited Speaker, “A Comprehensive Approach to HIV Prevention” at the “Drug Use, HIV, and Hepatitis: Bringing It All Together” Conference, Danya International, Baltimore, MD, May 7-10, 2000.
24. Invited Presentation, “Lessons from Rhode Island Syringe Access for New York.” The New York Academy of Medicine, NY, June 2000.
25. Invited Speaker, “HIV: Mind, Body and Spirit.” Fall River Health and Human Service 13th Annual AIDS Conference, North Dartmouth, MA, October 27, 2000.
26. Invited Speaker, “Hepatitis C: Controversies Facing the Primary Care Provider.” Brown Medical School, BRUNAP, Rhode Island Department of Health, Rhode Island Department of Corrections, Providence, RI, December 2, 2000.
27. Radio Interview: WNRI Radio, re: HIV Therapy, Providence, RI, February 7, 2001.
28. Invited Speaker, “Infections among Intravenous Drug Users,” Noon Conference Lecture Series, The Miriam Hospital, Providence, RI, February 13, 2001.
29. Invited Speaker, “Infections among Intravenous Drug Users,” Noon Conference Lecture Series, Rhode Island Hospital, Providence, RI, February 21, 2001.
30. Invited Panelist, “Patient Advocate Panel,” Brown Medical School, Providence, RI, March 7, 2001.
31. Invited Speaker: “AIDS in Drug Users in the US: The Rhode Island Experience,” 13th National HIV/AIDS Update Conference, San Francisco, CA, March 20-23, 2001.
32. Invited Speaker: “Stopping the Spread of HIV and Hepatitis C by Accessing Sterile Injecting Equipment,” Greater Fall River HIV/AIDS Consortium, Westport, MA, March 30, 2001.
33. Invited Presentation: “Physician Prescribing of Syringe Equipment to Injection Drug Users,” Massachusetts Medical Society Council Meeting, Boston, MA, April 10, 2001. 3
34. Invited Speaker: “Access to Syringes and Medical Care for Injection Drug Users,” Medical Grand Rounds, Memorial Hospital, Providence, RI, April 11, 2001.
35. Invited Speaker: “Syringe Access Among Injection Drug Users: Lessons for New York,” The Center for Comprehensive Care Educational Series, Roosevelt Hospital, New York, NY, May 14, 2001.
36. Invited Speaker: “Needle Exchange Programs: Minimizing the Spread of HIV and Hepatitis C,” Stanley Street Treatment and Resources (SSTAR), Fall River, MA, June 26, 2001.
37. Invited Speaker: “The Medical and Public Health Considerations of HIV/AIDS and Hepatitis C Prevention: Stopping the Spread of HIV and Hep C,” Stanley Street Treatment and Resources (SSTAR), Fall River, MA. June 27, 2001.
38. Burris S, Macalino G, Taylor L, McKenzie M, Zampi A, Osei A, Rich JD. Physician Prescribing of Syringes to Prevent HIV. 2001 National HIV Prevention Conference (Abstract 670), Atlanta, GA, August 12-15, 2001.
39. Taylor L, Runarsdottir V, Gross M, Macalino G, McKenzie M, Zampi A, Osei A, Burris S, Sanford S, Rich JD. Survey of Addiction Specialists: A Survey of Syringe Prescription for HIV Prevention. 2001 National HIV Prevention Conference (Abstract 894), Atlanta, GA, August 12-15, 2001.
40. Martin EG, Zampi AL, Taylor LE, Osei A, McKenzie M, McNamara SF, Rich JD. Prevalence of HIV and Hepatitis B and C among Injection Drug Users in a Syringe Prescription Program. 2001 National HIV Prevention Conference (Abstract 623), Atlanta, GA, August 12-15, 2001.
41. Rich JD, McKenzie M, Paul RV, Olson J, Osei A, Taylor LE, Zampi A, Francois A, Macalino G. Physician Prescribing of Syringes to Prevent HIV and Hepatitis. 2001 National HIV Prevention Conference (Abstract 650), Atlanta, GA, August 12-15, 2001.
42. Invited Speaker: “HIV Prevention Strategies via Syringe-exchange Programs,” Brigham & Women’s Hospital, HIV Clinical Conference, Boston, MA, October 29, 2001.
43. Invited Speaker: “The Politics of HIV and Injection Drug Use,” World AIDS Day Conference, Students for AIDS Awareness and the Brown Lecture Board, Brown Medical School, Providence, RI, December 1, 2001.
44. Guest Lecturer: “Health Care in Prisons,” Brown Medical School, Providence, RI, December 7, 2001.
45. Expert Witness: “Evidence that Access to Clean Syringes Leads to a Decrease in HIV Risk and not to an Increase in Injection Drug Use,” Senate Committee on Judiciary, State of Rhode Island, January 6, 2002.
46. Invited Speaker: “Update on HIV,” Medical Grand Rounds, Charlton Memorial Hospital, Fall River, MA, January 8, 2002.
47. Invited Plenary Speaker: "Hepatitis B Vaccination of Prisoners," Hepatitis Coordinators' Conference, San Antonio, TX, January 26-30, 2003.
48. Invited Speaker: "Methadone Maintenance: Facts, Controversies, and Issues for the 21st Century." NASW Criminal Justice and Alcohol, Tobacco, and Other Drugs Committees, Fulton Hall, Boston, College, Chestnut Hill, MA, March 3, 2003.
49. Invited Speaker: "Strategies in HIV correctional Care" Roundtable Panel, R&R healthcare Communications, Inc., New York City, NY, March 26, 2003.
50. Invited Speaker: 2003 National AIDS Drug Assistance Program Educational Conference, Washington, DC, May 15-18, 2003.
51. Invited Speaker: "ABCs of Hepatitis." A Special Forum to Discuss Viral Hepatitis and HCV/HIV Co-infection, State of Rhode Island and Providence Plantations, Department of Health, Greenville, RI, May 21, 2003.
52. Invited Speaker: "Patients Who Are Co-Infected with HIV and Hepatitis C." Presidential Advisory Council in HIV/AIDS (PACHA), Washington, DC, July 18, 2003.
53. Invited Speaker: "Responding to Co-Occurring Disorders." 3rd Annual New England Association of Drug Court Professionals Conference, Roger Williams University, Bristol, RI, July 25, 2003.
54. Invited Speaker: "Discharge Planning: Project Bridge". The University of Texas Medical Branch, School of Medicine, HIV Mini-Fellowship for Correctional Health Care Providers, Providence, RI, September 22-24, 2003.
55. Invited Speaker: "Failing Therapy - Adherence or Resistance?". HIV Management and Treatment Update, The Rhode Island Department of Corrections, Cranston, RI, October 17, 2003.
56. Invited Speaker: "Defining HCV Care and Accessing Health Care for the Drug Abuser in the Incarcerated Setting". NIH Conference, Washington, DC, November 13, 2003
57. Physicians for Human Rights (PHR) and CFR Africa Policy Studies Program (How the Bush Administration Can Prevent HIV Infections), Washington, DC, December 1, 2003.
58. Invited Speaker: "Overview of HIV Infection". Prevention and Treatment of Infectious Disease in Prison, What Corrections-Based Staff Need to Know. Rhode Island Dept. of Corrections in collaboration with Brown University AIDS Program, Warwick, RI, December 11, 2003.
59. Invited Discussant: "An Epidemic by the Numbers: Categorizing, Counting and Constructing AIDS". The Political and Symbolic Implications of Quantification Conference, Brown University, Providence RI, February 26-28, 2004.
60. Invited Attendee: "A Multicultural Caribbean Against HIV/AIDS Conference." Social and Scientific Systems, Inc., Santo Domingo, Dominican Republic, March 5-7, 2004.
61. Invited Participant: “Tar Wars Program, Henry Barnard School”. Rhode Island Medical Society Poster Competition, Roger Williams Park Carousel, Cranston, RI, May 8, 2004.
62. Invited Panelist: "Brown University Pandemic AIDS Symposium." Brown University, Providence, RI, April 23-25, 2004.
63. Invited Participant: "Challenges in Addressing Infectious Diseases Among Substance Users", Infectious Diseases Society of America (IDSA), Round Table Discussion, Boston Marriott Copley Place,Boston, MA, September 29, 2004.
64. Invited Participant: "Re-Accreditation by LCME". American Association of Medical Colleges and the American Medical Association, Site Visitors Meeting - Institutional Faculty Issues (Representing Chair of MFEC), Arnold Labs, Providence, RI, October 26, 2004.
65. Invited Attendee: "Memo of Understanding Signing (MOU), Providence/Samara (Russia) Partnership". Rhode Island State House, Governor's Office, Providence, RI, November 4, 2004.
66. Invited Attendee: “Female Offender Advisory Board Meeting”, Department of Corrections, Cranston, RI, November 9, 2004.
67. Invited Participant: "Prescribing Syringes to Injection Drug Users", 5th Annual Harm Reduction Conference, Working Under Fire: Drug Users Health and Justice, 2004, New Orleans, LA, November 11-14, 2004.
68. Invited Lecturer: “Advanced Infectious and Pulmonary Diseases”, Management of Infections in Injection Drug Users, URI College of Pharmacy, URI PHP 430 Providence, RI, April 5, 2005.
69. Invited Presenter: “Needle Exchange Program”, 57th Clinical Laboratory Science Society of Central New England, Annual Meeting, RI Convention Center, Providence, RI, May 11, 2005.
70. Invited Speaker: “Implementation of Hepatitis B Vaccination in Correctional Facilities”, Centers for Disease Control and Prevention, Division of Viral Hepatitis Consultation, Implementing Adult Hepatitis B Vaccination Meeting, Atlanta, GA, May 18, 2005.
71. Invented Speaker: Barriers to Adult Vaccination”, Centers for Disease Control and Prevention, Division of Viral Hepatitis Consultation, Implementing Adult Hepatitis B Vaccination Meeting, Atlanta, GA, May 18, 2005.
72. Invited Presenter: “Management of HIV Care in Hard to Reach Populations”, Johns Hopkins HIV Roundtable Discussion, HIV Management in Challenging Populations: Focusing on the Whole Patient, Chicago, IL, September 21, 2005.
73. Invited Presenter: “Comprehensive Medical Care for People Living with PLWH: Comorbidities”, Everything! Comprehensive Medical Care for PLWH Conference, HIV/AIDS Bureau, U.S. Department of Health and Human Services, Baltimore, MD, September 22, 2005.
74. Invited Speaker: “Treatment of Substance Abuse and HIV”, IDSA 43rd Annual Meeting, Management of HIV Infection, Interactive Session, San Francisco, CA, October 6-9, 2005.
75. Invited Presenter: “Blood Borne Pathogens Update”, Women & Infants Hospital Grand Rounds, Providence, RI, October 27, 2005.
76. Guest Lecturer: “Syringe Prescription to Prevent HIV Infection in Rhode Island: A Case Study”, AIDS in the International Perspective Seminar, Brown Medical School, Providence, RI, November 8, 2005.
77. Invited Speaker: “Treatment of Substance Abuse and HIV”, IDSA 43rd Annual Meeting, Management of HIV Infection, Interactive Session, San Francisco, CA, October 6-9, 2005.
78. Invited Speaker: “Faculty Promotion: All You Needed to Know”, Brown Medical School, Office of Medical Faculty Affairs, Providence, RI, February 15, 2006.
79. Conference Welcome: “Creating Bridges to Care”, AIDS Action Committee, Regional HIV, Hepatitis and Substance Use Conference, Providence, RI, March 22, 2006.
80. Invited Speaker: “Re-entry Strategies for Drug-Involved Parolees: The Rhode Island Experience”, Association of Paroling Authorities International, 2006 Training Conference, Reno, NV, April 23-26, 2006.
81. Conference Organizer and Presenter: “Ending the Revolving Door: Heroin and the Criminal Justice System in Rhode Island”, Methadone Conference, Holiday Inn, Providence, RI, May 19, 2006.
82. Invited Presenter: “How Community-based Organizations and Academic Health Centers Can Create Partnerships”, Coastal Medical, The Hotel Providence, Providence, RI, June 22, 2006.
83. Invited Speaker: “Treatment of HIV, HCV and Addiction in the Hispanic Population: Lessons from the Field”, Symposium: Pharmacotherapy of HIV Infection and Substance Abuse in Hispanic Populations, Scottsdale, AZ, September 13-15, 2006.
84. Invited Panelist: “Protecting the Rights of Detainees: The Role of the Health Professional” Panel Discussion, Part I Series: Advocacy in Medicine, Physician Advocacy Fellows, Institute on Medicine as a Profession, Columbia University, October 25, 2006.
85. Invited Speaker: “Harm Reduction”, Panel and Discussion. Ignite the Fight, HIV/AIDS Conference, Boston, MA, March 2-4, 2007.
86. Invited Participant: “Health Professional Summit on Global AIDS and US Policies for Injection Drug Users”, Physicians for Human Rights, Washington, DC, March 5-6, 2007.
87. Invited Participant: “Reentry strategies for drug-involved parolees: the Rhode Island experience.” Academic and Health Policy Correctional Health Care Conf, University of Massachusetts Medical School, Boston, MA, March 29-30, 2007.
88. Invited Participant: “In Her Mother’s Shoes” Symposium, The Global Threat of HIV Among Women: Challenges and Responses, Panel VI: Implementing Local HIV Prevention Initiatives, The Warren Alpert Medical School of Brown University, Providence, RI, May 5-6, 2007.
89. Invited Participant: “MAT in Prisons: Model Programs, Research and Evaluations”, Medication Assisted Therapy (MAT): Interventions for Drug Users in Correctional Settings Roundtable, Reno, American Correctional Health Services Association (ACHSA)NV, June 4, 2007.
90. Invited Participant: “Initiating Opioid Agonist Therapy in U.S. Jails and Prisons: Feasibility and Evidence from Three Ongoing Studies”. College on Problems of Drug Dependence Symposium, 68th Annual Scientific Meeting, The Hilton Quebec Hotel, Quebec City, Canada, June 16-21, 2007.
91. Invited Presenter: “Lifelines: Fundamentals of Pediatric Care for Transgender, Transsexual, Gender Variant and Intersex (TGI) Patients”. The Warren Alpert Medical School of Brown University, Department of Pediatrics Grand Rounds, August 3, 2007.
92. Invited Participant: “HIV Care in 2007 – State of the Art”. Tuskegee University College of Veterinary Medicine, Nursing and Allied Health (CVMNAH), 8th Annual Biomedical Research Symposium, Atlanta, GA, September 19-21, 2007.
93. Invited Participant: “Clinical Research and Epidemic of Incarceration”. Tuskegee University College of Veterinary Medicine, Nursing and Allied Health (CVMNAH), 8th Annual Biomedical Research Symposium, Atlanta, GA, September 19-21, 2007.
94. Invited Speaker: “Opportunities to Address Opiate Addiction in Correctional Populations”, Society of Correctional Physicians Annual Conference, Medicine in the Face of Addiction, Nashville, TN, October 13-17, 2007.
95. Invited Presenter: “Tar Wars”. Henry Barnard School, 2008 Tar Wars Rhode Island, Rhode Island Medical Society, March 7, 2008.
96. Invited Participant: Responsibilities of Medical Professionals in Reform of Sentencing, Diversion and Conditions of Confinement”, Second Annual Academic and Health Policy Conference on Correctiona Health Care, Boston, MA, March 29, 2008.
97. Invited Presenter: “The Importance of HIV Treatment and Care for Inmates and Continuity of Care Post-Release”, amfAR Congressional Briefing, “HIV in Correctional Settings: Implications for Prevention and Treatment Policy”, Washington, DC, April 22, 2008.
98. Invited Participant: “HIV Care in the Setting of Addiction” ASAM Workshop, 21st Cape Cod Symposium on Addictive Disorders, Hyannis, MA, September 4-7, 2008.
99. Presenting Author: “Supportive Re-Entry: Who Seeks Linkage to Community Methadone Treatment Upon Release from Incarceration”, Addiction Health Services Research (AHSR) 2008 Annual Meeting, Boston, MA, October 22, 2008.
100. Invited Speaker: “Rhode Island Needle Exchange”, 51st Annual Herber W. Youngken, Jr. Pharmacy Clinic, Radisson Airport Hotel, Warwick, RI, November 6, 2008.
101. Invited Participant: “Strategies in the Prevention and Treatment of HIV/AIDS”, 51st Annual Herber W. Youngken, Jr. Pharmacy Clinic, Radisson Airport Hotel, Warwick, RI, November 6, 2008.
102. Invited Participant: “Forum for Collaborative HIV Research”, 2008 National Summit on HIV Diagnosis, Prevention and Access to Care, The George Washington University, Arlington, VA, November 19-21, 2008.
103. Invited Speaker: “Harm Reduction: Overview, Evidence-Based Solutions, and Next Steps”, 2009 Physicians for Human Rights National Student Conference, Providence, RI, January 31-February 1, 2009.
104. Invited Participant: “Implementing Routine HIV Testing in Correctional Facilities: Challenges and Opportunities”, Forum for Collaborative HIV Research, The George Washington University, Washington, DC, April 27, 2009.
105. Invited Speaker: “HIV in Corrections”, American Society of Addiction Medicine Annual Medical-Scientific Conference, New Orleans, LA, April 30 - May 3, 2009.
106. Invited Participant: “First International Inaugural Meeting of Research Experts”, Network for Justice Health, Justice, Law and Crime Policy Program, George Mason University, Orlando, FL, May 5-8, 2009.
107. Invited Speaker: “Closing the Addiction Treatment Gap”, The United States Conference of Mayors, Children, Health and Human Services Standing Committee 77th Annual Meeting, June 12-16, 2009.
108. Invited Participant: “Physicians for Human Rights Leadership Summit: AIDS and the Right to Health”, Washington, DC, June 8-9, 2009.
109. Guest Appearance: “Prisons Not Treatting Drug Addiction Properly, Channel 10 News Interview, Providence, RI, September 8, 2009.
110. Invited Speaker: “A Physician’s Tale: Drugs, Sex…”, Colby College, Waterville, ME, September 17, 2009.
111. Invited Speaker: “Focus on Family”. Positive Action Against Chemical Addiction, Inc. (PAACA), New Bedford, MA, September 29, 2009.
112. Invited Participant: “4th National Scientific Meeting”, CFAR Social and Behavioral Sciences Research Network (SBSRN), Boston, MA, October 1-2, 2009.
113. Invited Speaker: “Opiate Addiction for Prisoners”, University of Pennsylvania Seminar, Philadelphia, PA, October 5-6, 2009.
114. Invited Speaker: “Human Rights”, Global Health Scholarly Concentration Seminar, Brown University, October 21, 2009.
115. Invited Participant: “International HIV Program”, Holiday Inn, Mansfield, MA, October 26, 2009.
116. Invited Speaker: “13th Annual 2009 National CFAR Conference & AETC-CCC HIV Clinical Symposium”, Vanderbilt University Medical Center, Nashville, TN, November 4-6, 2009.
117. Invited Speaker: “SERI Summit”, Bryant University, Smithfield, RI, November 12, 2009.
118. Invited Participant: “Public Health and Pretrial Detention Meeting”, Open Society Institute, Public Health Program and Open Society Justice Initiative, Columbia University, New York, NY, November 18, 2009.
119. Invited Participant: “Pretrial Detention and Its Links to Corruption, Public Health, Socio-Economic Factors, and Torture”, A Multi-Disciplinary Meeting, The Global Campaign for Pretrial Justice, Open Society Justice Initiative, New York, NY, November 19-20, 2009.
120. Invited Speaker: “3rd Annual Academic & health Policy Conference on Correctional Health”, Hilton Fort Lauderdale Airport Hotel, Fort Lauderdale, FL, December 3-4, 2009.
121. Invited Participant: “NIDA/IAS Criminal Justice Modeling Consultation Meeting”, Mayflower Hotel, Washington, DC, January 11-13, 2010.
122. Invited Speaker: “Issues in HIV Care in the Prison Setting”, Dartmouth-Hitchcock Medical Center, Lebanon, NH, April 12, 2010.
123. Invited Participant: “41st Annual Medical-Scientific Conference”, American Society of Addiction Medicine (ASAM), San Francisco, CA, April 15-18, 2010.
124. Invited Speaker: “16th Annual Training Conference: Putting a Drug Court Within Reach of Every American in Need”, National Association of Drug Court Professionals (NADCP), Alexandria, VA, June 2-5, 2010.
125. Invited Speaker: “Treatment and the Prison System”, The 23rd Annual Cape Cod Symposium on Addictive Disorders, Recovery Solutions, Cape Cod, MA, September 9-12, 2010.
126. Invited Participant: “OAR Social and Behavioral HIV Prevention Research Think Tank”, Bethesda, MD, September 26-29, 2010.
127. Invited Speaker: “Health and Human Rights of Prisoners”, University of Michigan, School of Public Health, 2010 Symposium, Ann Arbor, MI, October 3-4, 2010.
128. Invited Participant: University of Pennsylvania, School of Social Policy and Practice Seminar, Philadelphia, PA, October 14-15, 2010.
129. Invited Participant: “Buprenorphine-Assisted Treatment for Opiate Addiction in the Criminal Justice Context, a Framework for Practitioners and Policymakers”, MAT Guidelines Panel Meeting, Hilton Hotel, Chicago, IL, October 22, 2010.
130. Invited Speaker: “Incarceration and HIV Risk and Outcomes”, Incarceration and Health Disparities Symposium, Brigham and Women’s Hospital and The Harvard Clinical and translational Science Center, Brigham and Women’s Hospital, Boston, MA, March 9, 2011.
131. Guest Appearance: “Media Inquiries: Needle Exchange Funding” Microsoft/National Broadcasting Company (MSNBC), Interview, Providence, RI, 2011.
132. Invited Speaker: “Seek, Test and Treat: Addressing HIV in the Criminal Justice Population”, 4th Academic and Health Policy Conference on Correctional Health, Boston, MA, March 10-11, 2011.
133. Invited Presenter: “The Challenges of Pain Management in Corrections and Patients with HIV”, Rhode Island Department of Corrections, Cranston, RI, April 14, 2011.
134. Invited Presenter: “The Center for Prisoner Health and Human Rights Overview”, Center for Alcohol and Addiction Studies, Brown University, Providence, RI, April 29, 2011.
135. Invited Speaker: “Progress to Date from Brown University”, Criminal Justice Modeling Meeting, International Workshop on Treatment as Prevention (TasP), Vancouver, BC, Canada, May 3, 2011.
136. Invited Participant: “International Workshop on Treatment as Prevention (TasP)”, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, May 4 - 6, 2011.
137. Invited Participant: “Chief Resident Immersion Training (CRIT) Program”, Addiction Medicine: Improving Clinical and Teaching Skills for Generalists, Wequassett Inn, Chatham, MA, May 11-14, 2011.
138. Invited Lecturer: “US Prisons, The Corrections System and Associated HIV Risks”, Brown International Advanced Research Institutes (BIARI), Brown University, Providence, RI, June 21, 2011.
139. Invited Participant: “”NIDA Seek, Test, Treat, and Retain Data Harmonization Grantee Meeting: Criminal Justice Group”, Bethesda North Marriott Hotel and Conference Center, Bethesda, MD, August 16-17, 2011.
140. Invited Presenter: “Women and the American Correctional system: Pregnancy, Drugs, and the Imperative of Reform”, Department of Medicine, Rhode Island Hospital Grand Rounds, George Auditorium, Rhode Island Hospital, Providence, RI, September 13, 2011.
141. Invited Presenter: “Opiate Addiction and Incarceration”, Grand Rounds, Rhode Island Department of Corrections, Cranston, RI, September 22, 2011.
142. Invited Panelist: Einstein Expert Panel, “Medication-Assisted Treatment for Criminal Justice Populations, JBS International, Bethesda, MD, October 6-7, 2011. 145. Invited Panelist: “Chronic Pain and Opioids: Safe and Effective Management”, Norcal Mutual Insurance Company, Providence, RI, October 12, 2011.
143. Invited Participant: Expert Group Meeting, “Detention and Harm Reduction”, Open Society Institute, Vienna Consultation, Vienna, Austria, October 26-28, 2011. 147. Invited Speaker: “Medical and Public Health Opportunities and the Epidemic of Incarceration” Johns Hopkins School of Public Health, Baltimore, MD, November 10, 2011.
144. Invited Participant: “Advocacy Conference”, Center on Medicine as a Profession, Columbia University, November 17-18, 2011.
145. Invited Speaker: “Light the City Red” World AIDS Day, Rhode Island State House, Providence, RI, December 1, 2011.
146. Invited Speaker: “Medicine and Public Health Opportunities in the Epidemic of Incarceration” Institute of Medicine (IOM) Semi-Annual Board Meeting”, Institute of Medicine, Washington, DC, December 13, 2011.
147. Invited Presenter: “HIV and the Epidemic of Incarceration in the US: Implication for the Health Professions”, University of Puerto Rico, Center for Evaluation and Sociomedical Research, San Juan, PR, February 20-25, 2012.
148. Invited Speaker: “Addressing Social and Structural Determinants of the HIV Epidemic”, CFAR Social and Behavioral Sciences Research Network (SBSRN), 6th National Meeting, Chapel Hill, NC, March 1-2, 2012.
149. Invited Participant: “5th Academic and Health Policy Conference on Correctional Health”, Atlanta Airport Marriott Hotel, March 22-23, 2012.
150. Invited Participant: “HIV in Corrections and Beyond: Progress and Challenges”, Special Satellite Session, XIX International AIDS Conference, Washington, DC, July 22-27, 2012.
151. Invited Speaker: “Buprenorphine Diversion: Enhancing Access While Preventing Diversion” and “The Epidemic of Accidental/Inadvertent Overdoses on Prescription Drugs”, American Society of Addiction Medicine’s Annual Medical-Scientific Conference, Hilton Atlanta Hotel, Atlanta, GA, April 19-22, 2012.
152. Invited Participant: “Addiction Medicine: Research Training for Clinical Fellows”, 1st Annual Fellow Immersion Training (FIT) Program, Wequasett Inn, Chatham, MA, May 2-5, 2012.
153. Invited Presenter: “Incarcerated Populations”, BIARI Global Health HIV and AIDS, Brown University, Providence, RI, June 9-23, 2012.
154. Member Participation: “Committee on the Causes and Consequences of High Rates of Incarceration”, National Research Council of the National Academies, Second Meeting, Washington, DC, July 9-10, 2012.
155. Invited Participant/Presenter: “HIV in Corrections and Beyond: Progress and Challenges”, A Special Satellite Session, International AIDS Conference, Washington, DC, July 22, 2012.
156. Invited Presenter: “HIV and Incarceration”, Brigham and Women’s HIV Conference, Brigham and Women’s Hospital, Boston, MA, September 10, 2012.
157. Guest Appearance: “Medical Marijuana”, WGBH Radio Interview, Boston, MA October 9, 2012.
158. Invited Speaker: “Methadone Treatment for Opioid Addicts and Prevention of HIV”, Columbian Psychiatric Association and Its Subcommittee of Addictions, Cali, Colombia, October 11-14, 2012.
159. Invited Presenter: “Prison Medicine”, Brigham and Women’s Hospital, Boston, MA, October 22, 2012.
160. Guest Appearance: Nuestra Salud Latino Public Radio, Health Education Radio Show, International Infection Prevention Week for Audience Education, Providence, RI, October 29, 2012.
161. Guest Speaker: “Preventing Fatal Opioid Overdose: Q&A”, The Miriam Hospital, Providence, RI, November 15, 2012.
162. Discussant: “Workshop on Health and Incarceration”, National Research Council, The National Academies of Sciences, Washington, DC, December 5, 2012.
163. Member Participation/Presenter: “Committee on the Causes and Consequences of High Rates of Incarceration”, The National Academies Third Meeting, Washington, DC, December 6-7, 2012.
164. Invited Lecturer: “IDU’s and Harm Reduction Approaches”, HSPH Global AIDS Symposium, Harvard Medical School, December 13, 2012.
165. Invited Speaker: “Overdose Education and Naloxone From the Emergency Department”, Kent Hospital, December 20, 2012.
166. Invited Participant: “6th Academic and Health Policy Conference on Correctional Health”, Chicago Marriott O’Hare, Chicago, IL, March 21-22, 2013.
167. Invited Speaker: “AIDS Care Ocean State Pathways to Healthy Housing Conference”, Providence Biltmore Hotel, Providence, RI, April 2, 2013.
168. Member Participant: “Committee on the Causes and Consequences of High Rates of Incarceration”, The National Academies Fourth Meeting, Washington, DC, April 4-5, 2013.
169. Invited Member Speaker: “HIV, HCV and Addiction Behind Bars”, 2nd Annual Addiction Medicine for All Providers: A Risk Management Course”, The Massachusetts Medical Society; The Machusetts Society of Addiction Medicine”, Waltham, MA, June 21-22, 2013.
170. Member Participant: “Committee on the Causes and Consequences of High Rates of Incarceration”, The National Academies Fifth Meeting, Washington, DC, June 27, 2013.
171. Invited Presenter: “Methadone Treatment Program Project”, Connecticut Department of Corrections, Weathersfield, CT, July 15, 2013.
172. Guest Appearance: National Public Radio (NPR), “On Point” Live Broadcast (WBUR: 88.1 FM; 102.7 FM and 91.5 FM), “New Faces of Heroin”, Boston, MA, July 18, 2013. http://onpoint.wbur.org/2013/07/18/heroins-new-reach
173. Invited Speaker: “Infectious Diseases Grand Rounds Seminar Series”, Visiting Professor. Boston University Medical Center, Boston, MA, September 12, 2013.
174. Invited Speaker: “How Societal Perceptions of HIV/AIDS has Evolved”, Screening of Larson’s Rock Opera “Rent”, for the Preclinical Elective Course on Opera and Medicine, Warren Alpert Medical School, Brown University, Providence, RI, October 18, 2013.
175. Invited Speaker: “Incarcerated Populations” Brigham and Women’s Hospital, Social Justice Curriculum Session, Boston, MA, October 30, 2013.
176. Guest Appearance: National Public Radio (NPR), “On Point” Live Broadcast (WBUR: 88.1 FM; 102.7 FM and 91.5 FM), “A Plan to Reign-In Powerful Pain Medications”, Boston, MA, October 30, 2013. http://onpoint.wbur.org/2013/10/30/fda-oxycontin-hydrocodone
177. Guest Lecturer: “HIV/AIDS Interventions Course (GHP 255)”, Harvard Medical School, The Fenway Institute, Fenway Health, Boston, MA, November 7, 2013.
178. Invited Participant as Faculty and Co-Facilitator: “The Basics and Beyond: Research with Children, Pregnant Women and Fetuses, and Prisoners”, PRIM&R’s 2013 Advancing Ethical Research Conference (AER), Hynes Convention Center, Boston, MA November 8, 2013.
179. Invited Speaker: “Overdose Prevention Education and Take-Home Naloxone”, American Association for the Treatment of Opioid Dependence (AATOD), Philadelphia Marriott, Philadelphia, PA, November 9-13, 2013.
180. Invited Panel Speaker: “Prison Rape Issues in the U.S. Incarceration System” Harvard Law School, March 5, 2014.
181. Invited Panelist: “Opiate Addiction and Overdose Documentary”, Rhode Island Public Radio, Public Forum, Providence Athenaeum, Providence, RI, March 11, 2014.
182. Invited Visiting Professor Speaker: “Drug Legalization and Consequences from a Social Determinants of Health Perspective”, University of Puerto Rico, Center for Evaluation and Sociomedical Research, Puerto Rico Psycol Association, San Juan, PR, March 25-26, 2014.
183. Invited Presenter: “Breaking Down Silos”, Health Reform and Criminal Justice: Advancing New Opportunities, Hosted by Community Oriented Correctional Health Services (COCHS) and Health Affairs, The Columbus Club, Union Station, Washington, DC, April 3, 2014.
184. Invited Speaker: “An Epidemic of Opioid Overdose Deaths” Medicine Grand Rounds, Rhode Island Hospital, Providence, RI, April 8, 2014.
185. Invited Speaker: “Incarceration, HIV and Overdose”, Boston University School of Public Health, Crosstown Center, Boston, MA, April 9, 2014.
186. Guest Appearance: “New Face of Heroin”, NPR, Affiliate Radio Station, WHYY, Philadelphia, PA, April 14, 2014
187. Invited Webinar Panelist: “Health Behind Bars”, Center on Media, Crime and Justice, the Langeloth Foundation, April 29, 2014.
188. Invited Lecturer: “Human Rights and Incarceration”, Warren Alpert Medical School of Brown University, Providence, RI, May 7, 2014.
189. Invited Presenter: “Addressing HIV and Viral Hepatitis among Criminal Justice Populations”, Clinical AIDS Task Force, (CATF) and Brown University AIDS Program (BRUNAP), The Miriam Hospital, May 7, 2014.
190. Invited Lecturer: Public Health Opportunities of Incarceration”, National Health Insurance Administration, Taiwanese Association for Social Welfare, National Chung Cheng University, Taipei, Taiwan, Republic of China, May 19-26, 2014.
191. Invited Breakout Session Leader: “Substance Use and Mental Health Breakout Session: How Can We Incorporate this Substantive Issue into Public Health Education, Research, and Practice”, The Public Health Approach to Incarceration: Opportunities for Action Conference, Columbia University Mailman School of Public Health, New York, NY, June 2-4, 2014.
192. Invited Presenter: “Prescription Diversion summit, Alpert Medical School, Brown University, Providence, RI, June 7, 2014.
193. Invited Guest Keynote Speaker: “Public Health Opportunities of Incarceration”, Louisiana Public Health Institute, Stakeholder’s Meeting, New Orleans, LA, June 24, 2014.
194. Invited Attendee: “Whitehouse/Portman Women and Addiction Forum”, The Russell Senate Office Building, Washington, DC, July 21-22, 2014.
195. Expert Panelist: “Expert Panel on Law Enforcement and Naloxone”, Office of the Attorney General, Office of Justice Programs, Bureau of Justice Assistance and the Drug Enforcement Administration, Washington, DC, July 30-31, 2014.
196. Invited Panelist: “How Do We Significantly Reduce our Prisons? The NAS Report and Its Implications for New York”, John Jay College of Criminal Justice, New York, NY, September 3-4, 2014.
197. Invited Presenter: “Update in Opioid Prescription and Overdose Death”, Internal Medicine Grand Rounds, Dept. of Veterans Affairs, VA Hospital, Providence, RI, September 5, 2014.
198. Invited Participant: “National Institute on Drug Abuse (NIDA) Meeting”, Washington, DC, September 15-16, 2014.
199. Invited Presenter: “Incarceration, Public Health and an Epidemic of Fatal Opioid Overdoses”, Medicine Grand Rounds, University of Wisconsin, School of Medicine and Public Health, 2014 Health Disparities Symposium, “Incarceration, Infections and Inequalities: Creating an Agenda for Research and Community Action in Wisconsin”, University of Wisconsin, Madison School of Public Health, Visiting Professor Grand Rounds, Madison, WI, September 18-19, 2014.
200. Invited Panelist: “The Causes and Consequences of High Rates of Incarceration in the United States” and the “NRC Report on Incarceration”, Watson Institute for International Studies, Providence, RI, September 24, 2014.
201. Expert Faculty Clinician Webinar Seminar: “HIV Transmission Risk Behaviors Among Individuals Who are HIV Infected and were Recently Released from Jail: Park I”, Howard University College of Medicine, AETC-Capitol Region Telehealth Project, Washington, DC, October 8, 2014.
202. Expert Faculty Clinician Webinar Seminar: “HIV Transmission Risk Behaviors Among Individuals Who are HIV Infected and were Recently Released from Jail: Park II”, Howard University College of Medicine, AETC-Capitol Region Telehealth Project, Washington, DC, October 22, 2014.
203. Invited Speaker: “Physicians for Human Rights National Student Conference, Warren Alpert Medical School of Brown University, Providence, RI, November 8, 2014.
204. Invited Presenter: “20 Years Treating HIV Behind Bars: Lessons From the Field”, HIV, Substance Abuse and Criminal Justice T32 Fellowship Program, Columbia University School of Social Work, New York, NY, November 9-10, 2014.
205. Guest Appearance: “Health Check: Opioid Overdose Study”, WJAR TV Channel 10 News, Providence, RI, November 13, 2014.
206. Guest Lecturer: “Harm Reduction/Impact Mitigation in IDUs” Harvard Medical School, The Fenway Institute, Fenway Health, Boston, MA, November 13, 2014.
207. Invited Speaker: “Mass Incarceration and Health: Advocacy in Medicine and Beyond”, Harvard Medical School, Boston, MA, November 14, 2014.
208. Invited Presenter: “Methadone Maintenance for Opiate Addiction in Correctional Settings”, Grand Rounds, Rhode Island Department of Corrections, Cranston, RI, January 21, 2015.
209. Invited Speaker: “Health of Minorities in the US and Around the World”, MEDTalk Conference, Minority Association of Pre-Medical Students (MAPS), Warren Alpert Medical School of Brown University, Providence, RI, April 11, 2015.
210. Abstract Contributor: “Treatment of Opioid Use Disorder within Correctional Facilities”. The ASAM 46th Annual Conference, April 23-26, 2015, Hilton Hotel, Austin, TX.
211. Invited Roundtable Participant: “Exploring U.S.-Iran Academic Partnerships in Public Health and the Medical Sciences”, Institute of International Education, University at Albany, State University of New York, New York, NY, May 12, 2015.
212. Guest Appearance: “Methadone Continuation versus Forced Withdrawal on Incarceration in a Combined US Prison and Jail: A Randomized Open-Label Trial”, CBS Live Radio, Providence, RI, May 27, 2015.
213. Guest Appearance: “Methadone Behind Bars Keeps Addicted Inmates Off Drugs When Released”, Al Jazeera America, New York, NY, May 27, 2015.
214. Guest Appearance: “Methadone Continuation versus Forced Withdrawal on Incarceration in a Combined US Prison and Jail: A Randomized Open-Label Trial”, WJAR-TV, Channel 10, Providence, RI, May 29, 2015.
215. Invited White House Expert: “A Benefits Improvement and Integration Working Group”, Discussion of Care for Individuals Leaving the Prison System with HIV/AIDS and Other Chronic Conditions”, The White House, Office of National AIDS Policy, Domestic Policy Council, Eisenhower Executive Office Bldg., Washington, DC, June 18, 2015.
216. Member Participant: “Drug Policy Alliance Board Meeting”, New York, NY, June 22, 2015.
217. Guest Appearance: “The Consequences of the Rhode Island General Assembly’s Lack of Action on the Good Samaritan Law”, Al Jazeera’s American Tonight, On Camera Interview, Providence, RI, June 24, 2015.
218. Guest Appearance: The Consequences of the Rhode Island General Assembly’s Lack of Action on the Good Samaritan Law”, WLNE TV Channel 6 News, Providence, RI, June 26, 2015.
219. Invited Author Presenter: “HIV, Hepatitis C, Hepatitis B and TB in Prison and Closed Settings: A Global Review of Prevalence and Incidence”, The Lancet Series on HIV in Prisoners, Joint Peer Reviewers/Authors, and Editors’ Meeting, The Lancet Office and Tenter House, London, England, September 30 – October 1, 2015.
220. Invited Rounds Presenter: “Incarceration and Overdose in Rhode Island” Center for Alcohol & Addiction Studies (CAAS), Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, October 9, 2015.
221. Invited Presenter: “Rhode Island’s Multi-Pronged Response to the Opioid Crisis”, Addiction Professional Summit; A Community Event”, Crowne Plaza, Warwick, RI, November 6, 2015.
222. Invited Lecturer: “Injection Drug Users, Harm Reduction and Correctional Issues, HSPH Course, Harvard Medical School, November 10, 2015.
223. Invited Panelist: “Criminal Justice and Health Consortium” University of California, San Francisco, CA, November 11-15, 2015.
224. Member Participant: “CFAR/BUMC Collaborative Symposium”, Boston University, Boston, MA, November 18, 2015.
225. Member Participant: “Drug Policy Alliance Biennial 2015 International Drug Policy Reform Conference”, Washington, DC, November 18-21, 2015.
226. Guest Appearance: WJAR-TV (Channel 10 News), “Rhode Island Governor’s Overdose and Prevention Task Force to Combat Overdose”, Providence, RI, December 3, 2015
227. Invited Speaker: “Justice and Mental Health Collaboration/Second Chance in Action: Practical Strategies to Deliver Results National Conference”, Washington, DC, December 15-18, 2015.
228. Guest Appearance: National Public Radio (NPR), “On Point” Live Broadcast (WBUR: 88.1 FM; 102.7 FM and 91.5 FM), “Governor’s Overdose Prevention and Intervention Task Force”, Providence, RI, January 21, 2016.
229. Member Participant: “Drug Policy Alliance Board Meeting”, New York, NY, January 21-11, 2016.
230. Invited Presenter: “Opioid Overdose Prevention and Intervention Practices for Office Based Practitioners: Safe Opioid Prescribing Practice and Office Based Treatment of Opioid Use Disorders”, Warren Alpert Medical School of Brown University, Providence, RI, January 23, 2016.
231. Presenter: “How Doctors Can Stop the Overdose Epidemic in Rhode Island”, Medicine Grand Rounds, Rhode Island Hospital, February 9, 2016.
232. Guest Appearance: WNAC-TV, Fox Providence, Channel 12 Newscast, Live Interview: “Overdose Epidemic Affecting Southern New England, Providence, RI, February 19, 2016.
233. Invited Attendee: “4th Annual Meeting of the National Hepatitis Corrections Network (NHCN)”, Baltimore, MD, March 15-16, 2016.
234. Member Participant: “9th Academic & Health Policy Conference on Correctional Health”, Baltimore, MD, March 17-18, 2016.
235. Guest Appearance: ACLU of Rhode Island Monthly Cable Show Taping, “Overdose Prevention and Intervention Task Force”, PEG Studios, Providence, RI, March 22, 2016.
236. Invited Member: The National Academies of Sciences (NAS), “Workshop: Improving Collection of Indicators of Criminal Justice System Involvement in Population Health Data Programs”, Washington, DC, March 28-30, 2016.
237. Invited Speaker: “Buprenorphine”, Rhode Island Medical Society (RIMS) Council Meeting, Providence Marriott, Providence, RI, April 4, 2016.
238. Invited Speaker: “An Epidemic of Overdoses”, MEDTalk Conference, Brown University, April 8, 2016.
239. Invited Panelist: “The Future of Public Health”, Northeastern University School of Law Annual Conference, Raytheon Amphitheater, Egan Research Center, Northeastern University School of Law, Boston, MA, April 15, 2016.
240. Invited Panelist: “IPE Sessions”, Brown Medical School, Providence, RI, April 14-15, 2016.
241. Presenter: “How Doctors Started and Cn Stop the Overdose Epidemic in Rhode Island”, Emergency Medicine Grand Rounds, Rhode Island Hospital, Providence, RI, April 27, 2016.
242. Invited Speaker: “Gun Violence”, Rally, Rhode Island State House, April 28, 2016.
243. Invited Board Member: “4th Annual Advisory Board Meeting”, Global Institute for Health and Human Rights (GIHHR), University at Albany, Albany, NY, April 29-30, 2016.
244. Expert Advisory Panelist: “Reducing Mortality in Correctional Facilities”, National Institute of Justice, Arlington, VA, May 16-17, 2016.
245. Invited Speaker: “The Rhode Island Strategic Plan on Opioid Addiction and Overdose”, Addiction Medicine Rounds, Yale University, New Haven, CT, June 9, 2016.
246. Interview: “Five Questions with: Dr. Josiah D. Rich” Answers to PBN Questions Regarding: Governor Raimondo’s Overdose Prevention and Intervention Taskforce, Providence Business News (PBN), Weekly Health Care & Lifes Sciences Report Update, Providence, RI, June 13, 2016. 251. Invited Panelist: “Meet the Experts: Improving Outcomes for Justice Involved Populations with Behavioral Health Needs”, 3rd Annual P2PH Conference, John Jay Behavioral Health Symposium, John Jay College of Criminal Justice, New York, NY, June 14-15, 2016.
247. Member Participant: “Drug Policy Alliance Board Meeting”, New York, NY, June 22-23, 2016.
248. Invited Speaker/Presenter: “Clinical Care of Incarerated People with HIV, Viral Hepatitis, or Tuberculosis” (first author, Lancet Publication, Lancet Series), “2016 21st International AIDS Conference”, Durban, South Africa, July 18-22, 2016.
249. Live Interview: “HIV and Related Infections in Prisoners”, Lacet Series Discussed at the 2016 21st International AIDS Conference, Durban, South Africa, WJAR-TV, Channel 10 News, Providence, RI, July 28, 2016.
250. Invited Panelist: “Treatment Panel” Impaired Driving Prevention Alliance Summit, Community College of Rhode Island, Warwick, RI, August 25, 2016.
251. Invited Speaker: "Addiction Medicine Can Save Lives and Treat Addiction During and After Incarceration", The ASAM 48th Annual Conference - Innovations in Addiction Medicine and Science, New Orleans, LA, April 9-11, 2017.
252. Invited Grand Rounds Speaker: "Opioid Epidemic in RI", Newport Hospital, Newport, RI, May 4, 2017.
253. Invited Lecturer: "The Opioid Crisis: What you need to know", Rhode Island Hospital - Health and Wellness Lecture Series, Providence, RI, July 25, 2017.
254. Invited Panelist: "Municipal Responses to the Opiate Epidemic". Mayor Innovation Project, Burlington, VT, August 16-18, 2017.
255. Invited Presenter: " The Opioid Epidemic: How to Improve Care for all Rhode Islanders", Brown University, Providence, RI, September 18, 2017
256. Invited Speaker: "Efficacy of Vivitrol as a SUD [Substance Use Disorders] Treatment", 2017 International Drug Policy Reform Conference, Atlanta, GA, October 10-14, 2017.
257. Invited Grand Rounds Presenter: "The Opioid Epidemic: Lessons for Care Providers from a Statewide Strategic Plan", Allegheny Health Network, "Drug User Health: Promoting Health, Preventing Harm in Medical Settings" Conference, Pittsburgh, PA, October 18, 2017
258. Invited Speaker: The Center for Prisoner Health and Human Rights; Lifespan/Brown-Criminal Justice Research Training Program, Brown University, Providence, RI, October 23-26, 2017.
259. Invited Speaker: "Medication-Assisted Treatment and Justice-Involved Individuals", Illinois Criminal Justice Information Authority (ICJIA), "The Criminal Justice Response To The Opioid Crisis" Conference, Chicago, IL, November 1, 2017.
260. Invited Plenary Speaker: "Addiction Treatment for Incarcerated Populations (including Youth)" 41st Annual AMERSA National Conference, Washington, DC, November 2-4, 2017.
261. Invited Speaker: "Medical Assisted Treatments & Naloxone", 2017 Heroin Response Strateg Symposium, HIDTA, Atlanta, GA, November 7-8, 2017.
262. Invited Speaker: "Global Health", 2018 Brown University Internal Medicine Interview Informational Session, Providence, RI, December 8, 2017, and December 21, 2017.
263. Panel discussion: "New partnerships and reduced stigma are key to solving the opioid crisis" Brown University & the American Academy of Arts and Sciences. 2018
264. Invited Speaker: "Physiology of Addiction", C.O.A.A.S.T., South Kingstown, RI, January 15, 2018
265. Invited Speaker/Medical Trainer: "Prescribe-To-Save-Lives" Medical Community Program, Baystate Health, University of Massachusetts Medical School, Philadelphia, PA, January 26, 2018.
266. Invited Speaker: "Addiction & Overdose developing a new vision for Public Health response to the Opioid Epidemic focusing on prevention, harm reduction, treatment and progress Law Enforcement solutions", Bloomberg American Health Initiative Symposium, Johns Hopkins Bloomberg School, Baltimore, MD, February 7-8, 2018.
267. Invited Speaker: "Opioid Epidemic Update and Next Steps", RI Medical Society of Addiction Medicine and the RI Psychiatric Society, Providence, RI, February 12, 2018.
268. Invited Grand Rounds Speaker: James S. Winshall Memorial Visiting Professorship Program and Medical Grand Rounds, Brigham & Women's Hospital-Division of Genera Medicine and Primary Care,
Boston, MA, February 22-23, 2018.
269. "Correctional Health"; Session 2: "Opportunities for and Barriers to Treatment and Prevent"; "Workshop on Integrating Infectious Disease Considering with Response to the Opioid Epidemic", The National Academies of Sciences Engineering Medicine, Washington, DC, March 12-13, 2018.
270. Invited Speaker: "The Focus on Medically-Assisted Treatment", Opioid Crisis Presentation, RI Family Court Judiciary Conference, Providence, RI, October 4, 2018.
271. Invited Plenary Speaker and Panelist: "Plenary: Medical Care - Medication Assisted Treatment (MAT) for Prisoners diagnosed with Opioid Use Disorder", 2018 Prisoners' Advocates Conference, University of Denver - Sturm College of Law/Clinical Programs, Denver, CO, October 5, 2018.
272. Invited Speaker: "The Roles of Law Enforcement, Arrest and Prosecution", The Role of Drug Control Policies on Individual and Community Health for People of Color: A Workshop, National Academies of Sciences, Engineering, Medicine (NASEM), Washington, DC., October 8, 2018.
273. Invited Speaker: "Innovative approaches in Rhode Island Corrections", Minister's Opioid Emergency Response Commission Meeting, Canada's - Dept of Health, Minister's Opioid Emergency Response Commission (MOERC), Edmonton, Canada, October 29, 2018.
274. Invited Speaker and Panelist: "Opportunities and barriers - Social determinants of health and treatment for OUD", Public Workshop of the Committee on Medication-Assisted Treatment for Opioid Use Disorder, National Academies of Sciences, Engineering, Medicine (NASEM), October 30, 2018.
275. Invited Speaker: "Criminal Justice Involved Populations", Genoa Healthcare's Treatment of Opioid Use Disorder Course, American Society of Addiction Medicine (ASAM), Kingston, RI, November 12, 2018.
276. Invited Speaker: "Incarceration and the RI Overdoses and Intervention Task Force", Addiction Medicine Course, Brown University - School of Medicine, Providence, RI, November 15, 2018.
277. Invited Lecturer/Speaker: "Harm Reduction and Mitigation in IDU", Harvard Medical School of Public Health Course - GHP 255, Harvard Medical School, The Fenway Institute-Fenway Health, Boston, MA, December 11, 2018.
278. Invited Lecturer/Speaker: "HIV in the Correctional System", Winter Course Subject: HIV in diverse settings: Focus on Israel, Brown University - Undergraduate Course, Providence, RI, January 4, 2019.
279. Invited Speaker: "Overview of Opioid Use Disorder: The Epidemic and the crucial role P.A.'s can play.", Opioid Use Disorder Lecture, Johnson & Wales University-Physician Assistant Program, Providence, RI, March 14, 2019.
280. Invited Speaker: "Rhode Island's Public Healt11h approach to treatment of Opioid Use Disorder", 2019 Rhode Island Chapter Scientific Meeting, American College of Physicians (ACP) and Brown University, Providence, RI, March 20, 2019.
281. Invited Plenary Speaker and Panelist: "New Solutions: Above and Beyond: Treatment behind the Walls", 2019 NCADD-MD Tuerk Conference on Mental Health and Addiction Treatment, National Council on Alcoholism and Drug Dependence (NCADD) Maryland, Baltimore, MD., April 23, 2019.
282. Invited Plenary Speaker: "Linkage to Care", 2019 Rx Drug Abuse and Heroin Summit, National Conference on Addiction Disorders (NCAD) Advisory Board, Atlanta, GA, April 25, 2019.
283. Invited Speaker: "Updated Approaches to the Opioid Epidemic", RI Superior Court Judges Meeting, RI Superior Court Judges, Providence, RI, May 10, 2019.
284. Invited Speaker: COBRE Center on Opioids and Overdose, 2019 RI IDeA Symposium, Brown University - Dept. of Biology and Medicine, Providence, RI, June 7, 2019.
285. Invited Speaker: "Updated Approaches to the Opioid Epidemic", Human Trafficking Conference - "Making Progress: Engaging in partnership for prevention", RI Homeland Security Investigation; RI Human Trafficking Taskforce, Warwick, RI, June 24, 2019.
286. National Academies of Sciences, Engineering, and Medicine. 2022. Methadone Treatment for Opioid Use Disorder: Improving Access through Regulatory and Legal Change: Proceedings of a Workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/26635.
287. Invited Speaker: "Opioid Use Disorder and MOUD: 3 forms of MOUD, delivery mechanisms, and patient profiles", RI Judiciary, Providence, RI, October 26, 2022.
288. Commencement Forum: “Care and Custody: Past Responses to Mental Health”, https://www.nlm.nih.gov/exhibition/careandcustody/index.html. Brown University, Providence, RI, May 27, 2023.
| Year | Degree | Institution |
|---|---|---|
| 1991 | MPH | Harvard University |
| 1987 | MD | University of Massachusetts |
| 1982 | BA | Columbia University |
| Fellowship | Brigham and Women's Hospital, HIV /AIDS | 1991-1993 | Boston, MA |
| Fellowship Infectious Disease | Harvard Medical School, Beth Israel Hospital; Brigham and Women's Hospital; West Roxbury VA Medical Center; Children's Hospital; Dana Farber Cancer Institute, Infectious Diseases | 1991-1993 | Boston , MA |
| Residency | Emory University Affiliated Hospitals, Internal Medicine | 1988-1990 | Atlanta, GA |
| Intern | Emory University Affiliated Hospitals | 1987-1988 | Atlanta, GA |
1995-2002: Scientist Development Award for Clinicians, The National Institutes on Drug Abuse (NIDA)
1998: The Dr. Charles L. Hill Award, The Rhode Island Medical Society 18th Annual recipient of the Rhode Island Medical Society's Major Award "for service to the profession, the society and the community"
1998: Physician's Recognition Award, The American Medical Association
1999: The Miriam Hospital House Staff, Class of 1999, Award for "support and dedication to teaching"
2000: Master of Arts (ad eundem), Brown University
2000, 2016: Charles Hachadorian, Jr. Award, Rhode Island Pharmacists Association, "In recognition of his contribution to the profession of pharmacy and health care"
2000: AIDS Project Rhode Island, 2000 Community Service Award
2000-2002: Preceptorship Award, Rhode Island Hospital, The Miriam Hospital, and Brown University "as an outstanding teacher in the field of internal medicine"
2002: James H. Nakano Citation, The National Center for Infectious Diseases of the Centers for Disease Control and Prevention "for an outstanding scientific paper published in 2001"
2002: The State of Rhode Island and Providence Plantations Senate Citation "In Recognition of Your Dedication and Commitment to the Care of Patients and Their Families of The Providence Community Health Centers, Inc."
2003: The Rhode Island Community Planning Group for HIV Prevention, "The 2002 AIDS Leadership Award"
2004: AIDS Project Rhode Island, 2004 Red Ribbon Community Service Awards, World AIDS Day. "Medical Service Award"
2005: Soros Physician Advocacy Fellow
2006: CODAC's 35th Anniversary Celebration, "The Friend of the Field Award"
2006: Physicians for Human Rights, 20th Anniversary Celebration, "Honoree"
2009: Brown University Warren Alpert Medical School Eighth Annual Beckwith Family Award for Outstanding Teaching (youngest recipient on record)
2009: Nominee, Third Annual Riesman Family Excellence in Teaching Award
2012: Recipient, Neil J. Houston, Jr. Annual Memorial Award for “dedicated service and citizen Contribution towards the criminal justice profession and the public interest” for representing The Center of Prisoner Health and Human Rights
2013: Public Health Hero Designee Nominated by the Rhode Island Department of Health The Association of State and Health Territorial Officials (ASTHO) in coordination with the United Health Foundation America’s Health Rankings
2013: Recipient, Bertram Yaffe Award for “long standing service to the advancement of public health in Rhode Island” Sixteenth Annual Meeting of the Rhode Island Public Health Association, an Affiliate of the American Health Association
2016: Recipient/Winner, Cannistra Award for “commitment to caring for some of the state’s most disenfranchised patients while concurrently leading policy efforts around issues of HIV treatment and prevention, the justice system and addition medicine/overdose prevention” Selected by the Thundermist Health Center Board of Directors
2016: Recipient Joyce Ioanes Advocacy Award “To commemorate his work and honor him for the passion, dediction, leadership, and spirit with which he has advocated for individuals, diagnosed with substance use disorders and mental illness, for many years” State of Rhode Island, Department of Behavioral Healthcare, Developmental Disabilities and Hospitals
2016: Rhode Island Medical Society’s - "Herbert Rakatansky Award for Professionalism in Medicine”
2017: Charles “Bud” Kahn Lifetime Leadership Award, The Miriam Hospital
2017: "Department of Corrections' 2016 Teamwork Award" for dedication to caring for the health of the inmate population and staff at maximum security
2017: Rhode Island Health Center Association's (RIHCA) - John J. Cunningham, MD, Citizen's Award
2018: The Miriam Hospital's - "The Physician C.A.R.E. Award". In recognition for his outstanding contribution to The Miriam Hospital in enhancing Patient Experience
2018: 8th Annual, "James S. Winshall Memorial Visiting Professor in Primary Care", Brigham and Women's Hospital - Division of General Medicine and Primary Care.“In recognition of extraordinary accomplishments as a Doctor, Teacher, Mentor and Community Health and Social Justice Leader”
2018: Honorary Degree and Commencement Speaker The University of Toledo's - "2018 College of Medicine and Life Science's Commencement Speaker and Honorary Degree" candidate. "In recognition of his outstanding Scientific accomplishments, efforts to improve health care and his work related to addiction especially as it relates to the national opiate epidemic."
2018: Elected Member - National Academy of Medicine
2019: American Society of Addiction Medicine (ASAM). Certificate of Recognition."In recognition of his dedication and achievements in the field of Addiction Medicine."
2021: The Rhode Island HIV/STI Prevention Coalition World AIDS Day Award December 1, 2021
2023: Achievement in Equity Award from the National Consortium on Racial and Ethnic Fairness in the Courts. June 15, 2023
| DEA Controlled Substance License | US Dept. of Justice | 2023-Present | |
| American Board of Preventive Medicine, Addiction Medicine | American Board of Preventive Medicine, Addiction Medicine, Addiction Medicine | 2022-Present | |
| State of RI, Medical License | State of RI | 2002-2024 | |
| Certification | American Board of Internal Medicine, Internal Medicine | 2001- | |
| AAHIVM HIV Specialist | AAHIVM | 1995-2020 | |
| Diplomate, American Board of Internal Medicine, Infectious Disease | ABIM | 1994-2016 |
| Professor of Medicine and Epidemiology. Brown University, 2011-2020 |
| Medical Director. The Whitmarsh House, 2003-2011 |
| Staff. The Miriam Hospital, 2001-Present |
| Attending Physician. The Miriam Hospital, 1994-Present |
| Staff. Harvard Community Health Plan, 1991-1994 |
| Graduate Assistant in Medicine. Massachusetts General Hospital, 1990-1994 |
| Resident. Emory University Affiliated Hospitals, 1987-1990 |
1994 to present: Medical Attending Physician, The Miriam Hospital
1994 to present: Immunology Center Attending, The Miriam Hospital
1994 to present: Inpatient and On-call Rounding, The Miriam Hospital
1994-1999: Infectious Diseases Consult Service Attending, The Miriam Hospital
1995-1996: Lecturer, and Small Group Sessions Facilitator, Biomed 282 - Pathophysiology, Infectious Disease, Brown University
1995-1999: Course Co-Director, Biomed 282 - Pathophysiology, Infectious Disease, Brown University
1997 to present: Fogarty Fellowship Faculty Mentor, Brown International Health Institute
1997-1999: Speaker, Annual BRUNAP Forum, Brown University
1999: Guest Lecturer, Anthropology 23/ University Course/Biology and Medicine-Community, Health 23, Brown University
2000-2004: Regional Editorial Advisory Board Member, HEPP News (HIV Education Prison Project), Brown University AIDS Program
2002 to present: Infectious Diseases Consult Service Attending, Rhode Island Hospital
2003 to present: Preceptor, Internal Medicine Community Based Teaching Program, Brown Medical School and Lifespan Academic Medical Center
2003 to present: Mentor, Community Based Teaching Program, Residency Programs in Medicine,Brown Medical School
2003: Judge, Cost vs. Care: The Dilemma For American Medicine (BC007), Brown University
2004 to present: Regional Editorial Advisory Board Member, HEPP News (HIV Education Prison Project, Infectious Disease Correction Report), Brown University AIDS Program
2005: Educator, The Center of Excellence in Women's Health, Research Core Mentoring Program for Junior Investigators, "Substance Abusing Populations", Brown Medical School
2007-2008: Small Group Sessions Facilitator, Bio 365 Pathophysiology, Infectious Diseases, Brown University
2007: Course Speaker, HIV Medicine for Primary Care Providers, "HIV in Substance Users", Brown University
2008: Fellows Lecture Series, "Infections in Drug Users", The Miriam Hospital
2009: Small Group Sessions, "ID Pathophysiology Course", Brown Medical School
2009: Lecturer, Biology of AIDS, Warren Alpert Medical School of Brown University
2009: Lecturer and Small Group Sessions Facilitator Biomed 282 - Pathophysiology, Infectious Disease
2011: Invited Lecturer The Center for Prisoner Health and Human Rights Overview, Center for Alcohol and Addiction Studies
2011: Invited Lecturer US Prisons, The Corrections System and Associated HIV Risks, Brown International Advanced Research Institutes (BIARI)
2012: Invited Lecturer Incarcerated Populations, BIARI Global Health HIV and AIDS
2013: Course Instructor PHP1350 - Prisoner Health Inside Out, Brown University
2015: Invited Lecturer R25 Session “CJRT Corrections: HIV, HCV, Addiction in Criminal Justice Populations, Brown University School of Public Health
2015: Invited Speaker Health Policy Scholarly Concentration, Warren Alpert Medical School of Brown University
2016: Invited Speaker BIOL 0140A - Science and Medicine Communications Class “Methadone Continuation versus Forced Withdrawal on Incarceration in a Combined US Prison and Jail: A Randomized, Open-Label Trial”, Brown Medical School
2016: Invited Speaker Health Policy Course, Primary Care and Population Medicine “Physician Experiences Who Have Lobbied for Legislative and/or Regulatory Changes: Insights, Barriers, Facilitators.” Brown University School of Public Health
2016: Invited Panelist “Opioid Addiction and Needle Exchange Legislation” Health Policy Course, Primary Care and Population Medicine Program Brown University School of Public Health
2016: Invited Panelist “IPE Session I and IPE Session II” Brown Medical School.
2022: Invited Lecturer UNIV0450-Brown University Undergraduate Course “Parallels and Differences between the COVID-19 and HIV/AIDS Epidemics”
2023: Invited Lecturer GHP-255-Harvard School of Public Health Course HIV Interventions: Rational, Design and Evaluation Lecture "HIV and Substance Use”
